https://curecurrent.com/trials/leflunomide-methotrexate-in-rheumatoid-arthritis-104006https://curecurrent.com/trials/effects-of-medi-522-on-disease-activity-and-progression-of-joint-damage-in-patients-with-active-rheumatoid-arthritis-sub-104007https://curecurrent.com/trials/sex-steroids-in-sj-gren-s-syndrome-effect-of-substitution-treatment-on-fatigue-104008https://curecurrent.com/trials/medical-in-patient-rehabilitation-in-rheumatoid-arthritis-104009https://curecurrent.com/trials/a-comparison-of-methotrexate-alone-or-combined-to-infliximab-or-to-pulse-methylprednisolone-in-early-rheumatoid-arthriti-104010https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-etanercept-104011https://curecurrent.com/trials/mycophenolate-sodium-treatment-in-patients-with-primary-sjogren-s-syndrome-104012https://curecurrent.com/trials/quality-of-life-study-with-adalimumab-in-rheumatoid-arthritis-104013https://curecurrent.com/trials/remission-induction-in-very-early-rheumatoid-arthritis-104014https://curecurrent.com/trials/adalimumab-in-combination-with-methotrexate-vs-methotrexate-alone-in-early-rheumatoid-arthritis-104015https://curecurrent.com/trials/efficacy-of-humira-in-subjects-with-active-rheumatoid-arthritis-104016https://curecurrent.com/trials/adalimumab-administered-in-korean-rheumatoid-arthritis-subjects-treated-with-methotrexate-104017https://curecurrent.com/trials/tai-chi-for-patients-with-rheumatoid-arthritis-104018https://curecurrent.com/trials/dnaj-peptide-for-relieving-rheumatoid-arthritis-104019https://curecurrent.com/trials/monoarticular-corticosteroid-injection-versus-systemic-administration-in-the-treatment-of-rheumatoid-arthritis-patients-104020https://curecurrent.com/trials/the-effectiveness-of-a-nighttime-positioning-hand-splint-in-patients-with-rheumatoid-arthritis-104021https://curecurrent.com/trials/quantiferon-tb-gold-in-the-assessment-of-latent-tb-in-patients-candidate-to-treatment-or-treated-with-tnf-antagonists-104022https://curecurrent.com/trials/the-clinical-effectiveness-of-static-resting-splints-in-early-rheumatoid-arthritis-104023https://curecurrent.com/trials/the-effect-of-rituximab-on-the-humoral-response-to-influenza-vaccine-104024https://curecurrent.com/trials/open-label-steroid-reduction-study-of-adalimumab-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-104025https://curecurrent.com/trials/the-effect-of-low-dose-aspirin-on-the-pharmacokinetics-of-methotrexate-104026https://curecurrent.com/trials/comparison-of-neuflex-and-swanson-metacarpophalangeal-implants-for-rheumatoid-arthritis-104027https://curecurrent.com/trials/effects-of-home-based-emotional-disclosure-in-rheumatoid-arthritis-104028https://curecurrent.com/trials/omega-3-and-vitamin-e-supplementation-in-patients-with-rheumatoid-arthritis-104029https://curecurrent.com/trials/a-multicentre-trial-to-determine-the-efficacy-of-ad-452-in-ra-subjects-104030https://curecurrent.com/trials/development-and-evaluation-of-a-mailed-arthritis-self-management-program-104031https://curecurrent.com/trials/treatment-of-rheumatoid-arthritis-with-roxithromycin-104032https://curecurrent.com/trials/rheumatoid-arthritis-patients-in-training-104033https://curecurrent.com/trials/cardiovascular-outcomes-in-the-va-s-rheumatoid-arthritis-vara-population-104034https://curecurrent.com/trials/hanyang-university-medical-center-arthritis-network-104035https://curecurrent.com/trials/job-adaptation-in-patients-with-rheumatoid-arthritis-104036https://curecurrent.com/trials/omegaven-in-patients-with-rheumatoid-arthritis-ora-trial-104037https://curecurrent.com/trials/prevention-of-ectopic-bone-related-pain-and-disability-after-hip-replacement-surgery-with-peri-operative-ibuprofen-104038https://curecurrent.com/trials/prevention-of-glucocorticoid-induced-osteoporosis-in-rheumatic-diseases-alendronate-versus-alfacalcidol-104039https://curecurrent.com/trials/non-alcoholic-fatty-liver-disease-in-rheumatoid-arthritis-104040https://curecurrent.com/trials/dehydroepiandrosterone-administration-in-women-with-systemic-lupus-erythematosus-or-primary-sj-gren-s-syndrome-104041https://curecurrent.com/trials/intraarticular-opioids-vs-glucocorticosteroids-in-gonarthritis-104042https://curecurrent.com/trials/consistency-of-traditional-chinese-medicine-diagnoses-and-herbal-prescriptions-for-rheumatoid-arthritis-104043https://curecurrent.com/trials/study-of-human-anti-tnf-monoclonal-antibody-d2e7-in-subjects-with-active-rheumatoid-arthritis-104044https://curecurrent.com/trials/develop-biomarkers-for-assessing-ra-joint-erosion-104045https://curecurrent.com/trials/effectiveness-of-radon-spa-therapy-in-multimodal-rehabilitative-treatment-of-rheumatoid-arthritis-104046https://curecurrent.com/trials/the-effects-of-a-16-week-individualized-intensive-strength-training-program-in-patients-with-rheumatoid-arthritis-104047https://curecurrent.com/trials/decoy-receptor-3-dcr3-polymorphisms-in-rheumatoid-arthritis-ra-and-systemic-lupus-erythematosus-sle-104048https://curecurrent.com/trials/identification-of-cytokine-profiles-and-t-cell-subsets-among-immunosuppressed-patients-at-risk-of-developing-active-tube-104049https://curecurrent.com/trials/multicenter-randomized-prospective-trial-comparing-methotrexate-alone-or-in-combination-with-adalimumab-in-early-arthrit-104050https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-nc-503-in-secondary-aa-amyloidosis-104051https://curecurrent.com/trials/role-of-dcr3-in-t-cell-activation-in-sle-and-ra-104052https://curecurrent.com/trials/health-benefits-of-an-exercise-program-for-adults-with-arthritis-104053https://curecurrent.com/trials/program-evaluation-of-people-with-arthritis-can-exercise-104054https://curecurrent.com/trials/the-ratio-registry-of-infections-and-lymphoma-in-patients-treated-with-tnf-a-antagonists-104055https://curecurrent.com/trials/methotrexate-and-cyclosporine-in-treatment-of-early-rheumatoid-arthritis-104056https://curecurrent.com/trials/evaluation-of-the-active-living-every-day-exercise-program-for-people-with-arthritis-104057https://curecurrent.com/trials/safety-and-efficacy-of-a-monoclonal-antibody-for-treatment-of-rheumatoid-arthritis-104058https://curecurrent.com/trials/the-safety-and-efficacy-of-a-tumor-necrosis-factor-receptor-fusion-protein-on-uveitis-associated-with-juvenile-rheumatoi-104059https://curecurrent.com/trials/autologous-peripheral-blood-stem-cell-transplantation-in-patients-with-life-threatening-autoimmune-diseases-104060https://curecurrent.com/trials/assessment-of-the-frequency-of-functional-neurological-disorders-in-multiple-sclerosis-and-analysis-of-clinical-and-psyc-104061https://curecurrent.com/trials/identifying-immune-biomarkers-of-disease-and-disease-control-in-autoimmune-neurological-disease-using-autologous-haemato-104062https://curecurrent.com/trials/investigating-the-utility-of-demyelination-tracer-18f-3f4ap-in-controls-and-multiple-sclerosis-subjects-104063https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-ro7268489-as-add-on-therapy-to-ocrelizu-104064https://curecurrent.com/trials/a-study-of-orelabrutinib-in-patients-with-secondary-progressive-multiple-sclerosis-104065https://curecurrent.com/trials/cladribine-tablets-as-an-exit-therapy-strategy-104066https://curecurrent.com/trials/entire-body-pet-scans-for-multiple-sclerosis-104067https://curecurrent.com/trials/eccentric-cycling-in-multiple-sclerosis-rehabilitation-104068https://curecurrent.com/trials/a-non-interventional-study-evaluating-clinical-utility-and-implications-on-improved-patient-management-of-serum-neurofil-104069https://curecurrent.com/trials/the-effect-of-remotely-delivered-pilates-on-physical-and-psychological-outcomes-in-individuals-with-multiple-sclerosis-104070https://curecurrent.com/trials/unidimensional-self-efficacy-scale-for-multiple-sclerosis-use-ms-turkish-adaptation-104071https://curecurrent.com/trials/the-effect-of-health-belief-model-based-pelvic-floor-muscle-exercise-training-on-urinary-incontinence-and-quality-of-lif-104072https://curecurrent.com/trials/neurorehabilitation-of-cognitive-deficits-in-multiple-sclerosis-using-an-adaptive-cognitive-exergame-104073https://curecurrent.com/trials/effect-of-corticosteroids-on-inflammation-at-the-edge-of-acute-multiple-sclerosis-plaques-104074https://curecurrent.com/trials/jacobson-s-progressive-muscle-relaxation-for-fatigue-and-kinesiophobia-in-multiple-sclerosis-104075https://curecurrent.com/trials/a-study-of-orelabrutinib-in-patients-with-primary-progressive-multiple-sclerosis-104076https://curecurrent.com/trials/a-phase-1b-study-of-c-car168-in-participants-with-systemic-sclerosis-ssc-104077https://curecurrent.com/trials/enhancing-self-esteem-in-patients-with-multiple-sclerosis-a-randomised-controlled-trial-of-the-lexical-association-techn-104078https://curecurrent.com/trials/inductive-therapeutic-exercise-in-multiple-sclerosis-104079https://curecurrent.com/trials/effectiveness-of-a-one-year-group-program-for-fatigue-management-in-minimally-impaired-people-with-multiple-sclerosis-104080https://curecurrent.com/trials/comprehensive-multimodal-analysis-of-neuroimmunological-diseases-of-the-central-nervous-system-104081https://curecurrent.com/trials/alternate-pre-med-in-anti-cluster-of-differentiation-20-cd20-pilot-project-104082https://curecurrent.com/trials/bridging-gaps-in-the-multidimensional-assessment-and-management-of-overlapping-symptoms-in-multiple-sclerosis-and-functi-104083https://curecurrent.com/trials/a-clinical-study-to-evaluate-lvivo-tavec400-for-the-treatment-of-relapsed-refractory-autoimmune-diseases-104084https://curecurrent.com/trials/testosterone-treatment-for-erectile-dysfunction-and-multiple-sclerosis-104085https://curecurrent.com/trials/a-study-of-the-mind-diet-for-persons-with-multiple-sclerosis-104086https://curecurrent.com/trials/targeting-residual-activity-by-precision-biomarker-guided-combination-therapies-of-multiple-sclerosis-trap-ms-104087https://curecurrent.com/trials/stopping-tsc-onset-and-progression-2b-sirolimus-tsc-epilepsy-prevention-study-104088https://curecurrent.com/trials/gait-pattern-and-its-relation-to-cognition-and-vep-in-multiple-sclerosis-104089https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-imu-838-in-patients-with-relapsing-multiple-sclerosis-104090https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-imu-838-in-patients-with-relapsing-multiple-sclerosis-104091https://curecurrent.com/trials/esis-in-pediatric-dre-104092https://curecurrent.com/trials/cooling-during-inpatient-rehabilitation-in-persons-with-ms-104093https://curecurrent.com/trials/safety-and-tolerability-of-top-n53-applied-on-digital-ulcers-in-patients-with-systemic-sclerosis-104094https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-bms-986368-in-participants-with-multiple-sclerosis-spasticit-104095https://curecurrent.com/trials/oral-fmt-fecal-microbial-transplant-in-subjects-with-multiple-sclerosis-104096https://curecurrent.com/trials/advancing-portable-brain-imaging-the-nextmri-project-s-role-in-revolutionizing-diagnostic-mri-104097https://curecurrent.com/trials/a-study-of-ocrelizumab-administered-subcutaneously-in-participants-with-multiple-sclerosis-who-switch-from-an-approved-a-104098https://curecurrent.com/trials/psychological-interventions-for-multiple-sclerosis-effects-on-anxiety-depression-and-cognition-104099https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-ocrelizumab-in-participants-with-relaps-104100https://curecurrent.com/trials/hybrid-rehabilitation-approach-through-group-exercise-and-telerehabilitation-in-patients-with-multiple-sclerosis-104101https://curecurrent.com/trials/validation-of-the-becare-multiple-sclerosis-assessment-app-104102https://curecurrent.com/trials/educational-programs-based-on-healthy-habits-to-improve-quality-of-life-and-psychosocial-profile-in-women-with-neurodege-104103https://curecurrent.com/trials/epstein-barr-virus-antibodies-in-egyptian-patients-with-multiple-sclerosis-104104https://curecurrent.com/trials/safety-and-efficacy-of-av078-in-participants-with-tuberous-sclerosis-complex-tsc-refractory-epilepsy-restor-1-104105https://curecurrent.com/trials/a-phase-1-2a-study-of-oral-pro-1562-in-healthy-subjects-and-patients-with-relapsing-multiple-sclerosis-104106https://curecurrent.com/trials/study-of-skin-tumors-in-tuberous-sclerosis-104107https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-pk-of-a-higher-dose-of-ocrelizumab-in-adults-with-relapsing-104108https://curecurrent.com/trials/phase-2-basket-trial-of-nab-sirolimus-in-patients-with-malignant-solid-tumors-with-pathogenic-alterations-in-tsc1-tsc2-g-104109https://curecurrent.com/trials/effects-of-spinal-stabilization-on-the-pelvic-floor-in-women-with-multiple-sclerosis-104110https://curecurrent.com/trials/non-interventional-study-of-subcutaneous-ocrelizumab-in-persons-with-relapsing-remitting-multiple-sclerosis-104111https://curecurrent.com/trials/proof-of-concept-study-for-sar441344-frexalimab-in-relapsing-multiple-sclerosis-104112https://curecurrent.com/trials/a-study-of-disease-modifying-therapy-use-in-women-with-multiple-sclerosis-before-during-and-after-pregnancy-104113https://curecurrent.com/trials/neurocutaneous-syndromes-in-children-prevalence-and-clinical-characteristics-104114https://curecurrent.com/trials/evaluation-of-an-online-on-demand-multimodal-wellness-program-to-reduce-fatigue-and-improve-quality-of-life-in-progressi-104115https://curecurrent.com/trials/vancomycin-study-in-multiple-sclerosis-ms-104116https://curecurrent.com/trials/fighting-fatigue-in-multiple-sclerosis-tms-vs-tdcs-efficacy-104117https://curecurrent.com/trials/expanded-access-to-intrathecal-administration-of-autologous-mesenchymal-stem-cell-derived-neural-progenitors-msc-np-in-p-104118https://curecurrent.com/trials/investigation-of-the-prevalence-of-sarcopenia-and-dynapenia-according-to-disease-stage-in-patients-with-multiple-scleros-104119https://curecurrent.com/trials/clinical-investigation-of-the-quality-of-life-benefit-of-using-a-home-walking-exoskeleton-for-a-population-of-multiple-s-104120https://curecurrent.com/trials/aim-s-writing-for-healing-a-workshop-for-individuals-living-with-paralysis-104121https://curecurrent.com/trials/multiple-sclerosis-severity-and-caregiver-health-outcomes-104122https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-of-fenebrutinib-in-relapsing-multiple-sclerosis-rms-104123https://curecurrent.com/trials/the-canisleepinms-study-effect-of-cannabidiol-cbd-on-sleep-quality-in-patients-with-multiple-sclerosis-104124https://curecurrent.com/trials/understanding-the-impact-of-meal-timing-on-neurological-health-in-adults-with-multiple-sclerosis-104125https://curecurrent.com/trials/a-phase-2a-study-of-sun-627-in-participants-with-non-active-secondary-progressive-and-primary-progressive-multiple-scler-104126https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-pipe-307-in-subjects-with-relapsing-remitting-multiple-sclerosis-104127https://curecurrent.com/trials/this-is-an-extension-study-of-the-roche-p-trials-to-investigate-safety-and-effectiveness-of-ocrelizumab-in-participants-104128https://curecurrent.com/trials/a-study-evaluating-the-presence-and-concentration-of-briumvi-ublituximab-in-breast-milk-104129https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-biib017-peginterferon-beta-1a-in-pediatric-participants-for-104130https://curecurrent.com/trials/a-study-to-evaluate-white-matter-hyperintensities-in-migraine-104131https://curecurrent.com/trials/traditional-versus-early-aggressive-therapy-for-multiple-sclerosis-trial-104132https://curecurrent.com/trials/aerobic-exercise-for-remyelination-in-multiple-sclerosis-104133https://curecurrent.com/trials/a-study-of-ly3541860-in-adult-participants-with-relapsing-multiple-sclerosis-104134https://curecurrent.com/trials/use-of-a-portable-pupillometer-to-detect-optic-nerve-impairment-in-patients-with-suspected-multiple-sclerosis-104135https://curecurrent.com/trials/an-extension-study-of-ublituximab-in-participants-with-relapsing-multiple-sclerosis-104136https://curecurrent.com/trials/tweak-a-new-biomarker-for-predicting-inflammatory-relapses-in-multiple-sclerosis-104137https://curecurrent.com/trials/the-effects-of-high-intensity-interval-training-on-gait-balance-and-cognitive-functions-in-individuals-with-multiple-scl-104138https://curecurrent.com/trials/a-study-evaluating-the-real-world-experience-of-participants-treated-with-briumvi-ublituximab-xiiy-for-relapsing-multipl-104139https://curecurrent.com/trials/clinnova-ms-a-prospective-cohort-study-of-patients-with-multiple-sclerosis-a-trans-regional-digital-health-effort-unlock-104140https://curecurrent.com/trials/fatigue-alleviation-through-neuromodulating-therapy-in-multiple-sclerosis-104141https://curecurrent.com/trials/comparison-between-abp-692-and-ocrevus-ocrelizumab-104142https://curecurrent.com/trials/propionic-acid-for-multiple-sclerosis-safety-and-benefits-104143https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-safety-radiological-and-clinical-effects-of-subcutaneous-ublit-104144https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-fenebrutinib-compared-with-teriflunomide-in-relapsing-multiple-sclerosis-104145https://curecurrent.com/trials/ms-neuroplast-neuroplasticity-of-cortical-areas-induced-by-cognitive-training-in-patients-with-multiple-sclerosis-104146https://curecurrent.com/trials/treatment-of-participants-with-primary-or-secondary-progressive-multiple-sclerosis-104147https://curecurrent.com/trials/a-study-evaluating-the-effect-of-briumvi-ublituximab-on-pregnancy-and-infant-outcomes-in-participants-with-multiple-scle-104148https://curecurrent.com/trials/study-to-evaluate-safety-efficacy-and-pharmacokinetics-pk-of-a-modified-regimen-of-ublituximab-104149https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetics-pk-and-safety-of-subcutaneous-sc-ublituximab-administered-at-various-injection-site-104150https://curecurrent.com/trials/study-to-assess-effects-of-ublituximab-in-pediatric-participants-with-relapsing-forms-of-multiple-sclerosis-104151https://curecurrent.com/trials/exploring-reproductive-decision-making-among-women-with-multiple-sclerosis-104152https://curecurrent.com/trials/association-between-peripheral-immune-biomarkers-and-functional-performance-in-multiple-sclerosis-104153https://curecurrent.com/trials/in-vivo-characterization-of-inflammation-with-ferumoxytol-an-ultrasmall-superparamagnetic-iron-oxide-nanoparticle-on-7-t-104154https://curecurrent.com/trials/efficacy-of-diet-on-quality-of-life-in-multiple-sclerosis-104155https://curecurrent.com/trials/a-study-to-evaluate-the-preliminary-efficacy-and-safety-of-terfenadine-in-patients-with-relapsing-remitting-multiple-scl-104156https://curecurrent.com/trials/motor-imagery-and-action-observation-for-gait-function-in-ms-104157https://curecurrent.com/trials/effect-of-combined-exercise-training-in-patients-with-multiple-sclerosis-104158https://curecurrent.com/trials/web-intervention-for-parents-of-youth-with-genetic-syndromes-wings-104159https://curecurrent.com/trials/dietary-approaches-to-treat-multiple-sclerosis-related-fatigue-study-104160https://curecurrent.com/trials/prevalence-of-primary-headache-in-multiple-sclerosis-patients-104161https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-fenebrutinib-compared-with-ocrelizumab-in-adult-participants-with-primary-104162https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-fenebrutinib-compared-with-teriflunomide-in-relapsing-multiple-sclerosis-rm-104163https://curecurrent.com/trials/delivery-of-a-culturally-tailored-exercise-training-intervention-for-hispanics-with-multiple-sclerosis-104164https://curecurrent.com/trials/body-awareness-trunk-stability-and-arm-function-in-ms-104165https://curecurrent.com/trials/aerobic-fitness-in-multiple-sclerosis-the-relationship-between-balance-and-sensory-dual-tasking-104166https://curecurrent.com/trials/a-phase-iv-study-of-safety-and-efficacy-of-everolimus-in-taiwanese-patients-with-tuberous-sclerosis-complex-who-have-ren-104167https://curecurrent.com/trials/a-study-of-imaging-in-demyelinating-diseases-104168https://curecurrent.com/trials/a-study-of-c-car168-in-participants-with-progressive-multiple-sclerosis-104169https://curecurrent.com/trials/monitoring-intensity-during-balance-training-in-persons-with-multiple-sclerosis-104170https://curecurrent.com/trials/magnetic-resonance-imaging-mri-to-evaluate-activity-of-multiple-sclerosis-ms-104171https://curecurrent.com/trials/best-available-therapy-versus-autologous-hematopoietic-stem-cell-transplant-for-multiple-sclerosis-beat-ms-104172https://curecurrent.com/trials/propionic-acid-in-multiple-sclerosis-104173https://curecurrent.com/trials/fes-effect-on-walking-in-the-real-world-and-participation-in-daily-life-in-people-with-multiple-sclerosis-104174https://curecurrent.com/trials/a-real-world-study-of-ofatumumab-in-multiple-sclerosis-patients-in-germany-and-japan-104175https://curecurrent.com/trials/non-inferiority-study-of-frexalimab-subcutaneous-administration-compared-to-intravenous-administration-in-adult-particip-104176https://curecurrent.com/trials/treatment-of-cognitive-deficits-in-multiple-sclerosis-with-high-definition-transcranial-direct-current-stimulation-104177https://curecurrent.com/trials/a-study-to-investigate-effects-of-ocrelizumab-treatment-on-neurofilament-light-chain-nfl-levels-and-participant-satisfac-104178https://curecurrent.com/trials/a-biospecimen-collection-study-to-identify-the-targets-of-disease-reactive-t-cells-in-patients-with-autoimmune-disease-104179https://curecurrent.com/trials/cannabis-thc-vs-cbd-in-multiple-sclerosis-104180https://curecurrent.com/trials/the-effects-of-internet-based-and-supervised-exercise-programs-in-people-with-multiple-sclerosis-104181https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-processing-by-the-body-of-intravenous-and-subcutaneous-ro7121932-admi-104182https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-efficacy-of-gt802-injection-in-the-treatment-of-relapsing-refractory-multipl-104183https://curecurrent.com/trials/a-closed-loop-doctor-to-patient-mobile-application-for-depression-in-people-with-multiple-sclerosis-104184https://curecurrent.com/trials/a-study-of-ocrelizumab-in-children-and-adolescents-with-relapsing-remitting-multiple-sclerosis-104185https://curecurrent.com/trials/the-exopulse-study-a-database-for-routine-follow-up-of-clinical-outcomes-104186https://curecurrent.com/trials/comparative-study-of-two-vaccination-schedules-for-the-subunit-herpes-zoster-vaccine-in-multiple-sclerosis-and-neuromyel-104187https://curecurrent.com/trials/a-phase-2-multicenter-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-safety-and-tolerability-104188https://curecurrent.com/trials/first-in-human-fih-study-of-aln-sod-in-adult-participants-with-amyotrophic-lateral-sclerosis-associated-with-mutation-in-104189https://curecurrent.com/trials/study-of-diosmin-for-the-treatment-of-digital-ulcers-in-systemic-sclerosis-104190https://curecurrent.com/trials/a-multiple-dose-study-to-investigate-safety-tolerability-and-pharmacokinetics-of-tbn-104191https://curecurrent.com/trials/high-intensity-interval-training-for-walking-and-function-across-different-multiple-sclerosis-disability-levels-104192https://curecurrent.com/trials/controlling-amyotrophic-lateral-sclerosis-motor-neuron-excitability-study-104193https://curecurrent.com/trials/study-to-evaluate-the-effectiveness-and-safety-of-ozanimod-compared-to-fingolimod-in-children-and-adolescents-with-relap-104194https://curecurrent.com/trials/effects-of-virtual-reality-on-sleep-quality-and-mental-well-being-104195https://curecurrent.com/trials/the-mediating-role-of-balance-in-the-relationship-between-fatigue-and-fear-of-falling-in-individuals-with-multiple-scler-104196https://curecurrent.com/trials/a-pharmacokinetics-pk-pharmacodynamics-pd-safety-and-tolerability-study-of-fenebrutinib-in-children-and-adolescents-with-104197https://curecurrent.com/trials/effect-of-high-intensity-training-on-motor-and-cognitive-functions-104198https://curecurrent.com/trials/emerging-indications-for-hyperbaric-oxygen-treatment-104199https://curecurrent.com/trials/a-safety-and-efficacy-study-evaluating-ctx112-in-subjects-with-refractory-neurologic-autoimmune-disease-104200https://curecurrent.com/trials/a-study-to-assess-the-safety-and-clinical-activity-of-azer-cel-in-participants-with-b-cell-mediated-autoimmune-disorders-104201https://curecurrent.com/trials/vigip-sep2-training-of-patients-by-nurses-on-adr-reporting-by-rrms-patient-via-an-app-104202https://curecurrent.com/trials/human-amniotic-mesenchymal-cell-secretome-for-neurodegeneration-and-neuroinflammation-104203https://curecurrent.com/trials/clinical-pilates-for-balance-and-function-in-multiple-sclerosis-104204https://curecurrent.com/trials/clinical-investigation-to-validate-the-safety-and-performance-of-integrating-functional-electrical-stimulation-into-the-104205https://curecurrent.com/trials/sizomus-safety-of-ixazomib-targeting-plasma-cells-in-multiple-sclerosis-104206https://curecurrent.com/trials/chariotms-cladribine-to-halt-deterioration-in-people-with-advanced-multiple-sclerosis-104207https://curecurrent.com/trials/18f-f-ded-pet-imaging-of-reactive-astrocytes-in-multiple-sclerosis-104208https://curecurrent.com/trials/short-sprint-interval-training-in-people-with-multiple-sclerosis-104209https://curecurrent.com/trials/open-label-multi-center-phase-i-ii-study-to-assess-safety-disease-progression-and-cellular-kinetics-following-ytb323-adm-104210https://curecurrent.com/trials/early-symptoms-in-multiple-sclerosis-an-investigation-using-fmri-and-gait-analysis-to-develop-personalized-balance-train-104211https://curecurrent.com/trials/confirmatory-trial-for-alleviating-fatigue-in-multiple-sclerosis-104212https://curecurrent.com/trials/the-hit-hard-and-hit-early-in-multiple-sclerosis-trial-104213https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetics-safety-tolerability-immunogenicity-and-pharmacodynamic-effects-of-subcutaneous-ocre-104214https://curecurrent.com/trials/simultaneous-t2-flair-and-t1-brain-mri-with-enraged-flair-in-multiple-sclerosis-104215https://curecurrent.com/trials/kinesiophobia-associated-with-fatigue-in-patients-with-multiple-sclerosis-104216https://curecurrent.com/trials/a-study-of-subcutaneously-administered-ro7845860-in-participants-with-relapsing-multiple-sclerosis-104217https://curecurrent.com/trials/phase-2-study-evaluating-rapcabtagene-autoleucel-in-participants-with-diffuse-cutaneous-systemic-sclerosis-104218https://curecurrent.com/trials/an-online-nurse-led-purpose-focused-group-program-for-adult-women-with-multiple-sclerosis-effects-on-meaning-and-quality-104219https://curecurrent.com/trials/the-setpoint-system-as-a-pro-remyelination-therapy-for-relapsing-remitting-multiple-sclerosis-a-pilot-study-104220https://curecurrent.com/trials/comparing-the-safety-and-benefit-of-natalizumab-tysabri-at-home-infusion-vs-at-hospital-infusion-in-multiple-sclerosis-104221https://curecurrent.com/trials/an-open-label-study-to-assess-the-safety-efficacy-and-cellular-kinetics-of-ytb323-in-relapsing-multiple-sclerosis-104222https://curecurrent.com/trials/ocrelizumab-discontinuation-in-relapsing-multiple-sclerosis-104223https://curecurrent.com/trials/feasibility-and-effectiveness-of-a-mindfulness-program-delivered-by-web-to-patients-during-hospitalization-and-caregiver-104224https://curecurrent.com/trials/home-rehabilitation-as-continuity-of-care-in-ms-104225https://curecurrent.com/trials/determining-the-effectiveness-of-early-intensive-versus-escalation-approaches-for-rrms-104226https://curecurrent.com/trials/natural-history-study-of-progressive-multifocal-leukoencephalopathy-pml-104227https://curecurrent.com/trials/ms-related-disability-worsening-and-thalamic-volume-loss-104228https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-a-full-body-electrostimulation-garment-for-individuals-with-neurological-and-ne-104229https://curecurrent.com/trials/impact-of-annual-versus-biannual-infusions-of-ocrelizumab-in-patients-with-active-ms-after-2-years-of-initial-treatment-104230https://curecurrent.com/trials/identifying-and-characterizing-preclinical-ms-104231https://curecurrent.com/trials/reliability-and-validity-of-three-dt-tug-protocols-in-ms-104232https://curecurrent.com/trials/emotional-processing-family-life-friendship-and-social-integration-in-patients-with-multiple-sclerosis-104233https://curecurrent.com/trials/synbiotic-supplementation-as-a-part-of-dietary-modification-in-multiple-sclerosis-104234https://curecurrent.com/trials/efficacy-and-safety-of-remibrutinib-after-switching-from-ocrelizumab-in-participants-living-with-relapsing-multiple-scle-104235https://curecurrent.com/trials/assessment-of-potential-for-chronic-liver-injury-in-participants-treated-with-epidiolex-cannabidiol-oral-solution-104236https://curecurrent.com/trials/intermittent-theta-burst-stimulation-for-lower-limb-spasticity-and-pain-in-multiple-sclerosis-104237https://curecurrent.com/trials/cone-evasion-walk-test-in-multiple-sclerosis-104238https://curecurrent.com/trials/development-of-pain-management-jitai-content-in-multiple-sclerosis-and-spinal-cord-injury-104239https://curecurrent.com/trials/the-role-of-the-fcrl5-protein-in-the-pathophysiology-of-multiple-sclerosis-and-response-to-treatment-104240https://curecurrent.com/trials/an-open-label-study-of-azd0120-in-adults-with-multiple-sclerosis-104241https://curecurrent.com/trials/fatigue-investigation-using-digital-outcomes-104242https://curecurrent.com/trials/amt-260-gene-therapy-study-in-adults-with-unilateral-refractory-mesial-temporal-lobe-epilepsy-104243https://curecurrent.com/trials/a-basket-study-of-cta313-in-participants-with-active-autoimmune-diseases-104244https://curecurrent.com/trials/roll-over-study-to-collect-and-assess-long-term-safety-of-everolimus-in-patients-with-tsc-and-refractory-seizures-who-ha-104245https://curecurrent.com/trials/a-study-comparing-effectiveness-of-kesimpta-ofatumumab-versus-ocrevus-ocrelizumab-in-real-world-practice-104246https://curecurrent.com/trials/coupled-gentamicin-lactobacillus-rhamnosus-in-nlutd-104247https://curecurrent.com/trials/a-study-of-rocbrutinib-in-prl-positive-relapsing-remitting-multiple-sclerosis-104248https://curecurrent.com/trials/train-bw-backward-walking-training-in-multiple-sclerosis-104249https://curecurrent.com/trials/brain-and-behavioral-influences-on-motor-skill-learning-in-multiple-sclerosis-104250https://curecurrent.com/trials/a-study-of-remibrutinib-using-mr-imaging-in-relapsing-or-progressive-ms-104251https://curecurrent.com/trials/efficacy-and-safety-of-remibrutinib-compared-to-teriflunomide-in-participants-with-relapsing-multiple-sclerosis-rms-remo-104252https://curecurrent.com/trials/pain-phenotypes-in-individuals-with-multiple-sclerosis-104253https://curecurrent.com/trials/efficacy-and-safety-of-remibrutinib-compared-to-teriflunomide-in-participants-with-relapsing-multiple-sclerosis-rms-remo-104254https://curecurrent.com/trials/a-study-of-ltx-002-in-adult-participants-with-amyotrophic-lateral-sclerosis-104255https://curecurrent.com/trials/effects-of-face-to-face-versus-telerehabilitation-based-circuit-training-in-people-with-multiple-sclerosis-104256https://curecurrent.com/trials/music-4-ms-to-improve-cognition-in-people-living-with-multiple-sclerosis-a-feasibility-study-104257https://curecurrent.com/trials/electrical-stimulation-exercise-for-individuals-with-lower-limb-paralysis-104258https://curecurrent.com/trials/non-inferiority-study-of-ocrelizumab-and-rituximab-in-active-multiple-sclerosis-104259https://curecurrent.com/trials/plasmatic-extracellular-vesicles-as-biomarkers-of-neural-tissue-damage-104260https://curecurrent.com/trials/a-study-to-investigate-long-term-safety-and-tolerability-of-tolebrutinib-in-participants-with-multiple-sclerosis-104261https://curecurrent.com/trials/evaluating-the-use-of-oral-indapamide-to-reduce-disabiltiy-progression-in-progressive-multiple-sclerosis-ms-104262https://curecurrent.com/trials/hypnosis-and-attention-in-patients-with-a-neurological-disease-stroke-traumatic-brain-injury-and-multiple-sclerosis-104263https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-kite-363-in-relapsed-refractory-autoimmune-neurologic-diseases-104264https://curecurrent.com/trials/privosegtor-investigation-in-optic-neuropathies-efficacy-evaluation-research-104265https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-pharmacokinetics-immunogenicity-and-pharmacodynamics-of-a-new-subcutaneou-104266https://curecurrent.com/trials/predictors-of-progression-independent-of-relapse-activity-in-relapsing-remitting-multiple-sclerosis-104267https://curecurrent.com/trials/effect-of-artificial-intelligence-based-cognitive-training-on-sleep-disorders-and-quality-of-life-in-patients-with-multi-104268https://curecurrent.com/trials/novel-imaging-markers-in-spms-104269https://curecurrent.com/trials/effect-of-music-therapy-on-pain-in-people-with-multiple-sclerosis-104270https://curecurrent.com/trials/vista-protein-expression-of-monocyte-and-t-cell-subsets-in-multiple-sclerosis-and-its-clinical-correlation-104271https://curecurrent.com/trials/artificial-intelligence-assisted-magnetic-resonance-imaging-for-quality-efficiency-and-equity-in-the-national-health-ser-104272https://curecurrent.com/trials/concentration-of-ofatumumab-in-the-breast-milk-of-lactating-women-with-relapsing-forms-of-multiple-sclerosis-104273https://curecurrent.com/trials/a-phase-iii-non-inferiority-randomized-open-label-parallel-group-multicenter-study-to-investigate-the-pharmacokinetics-p-104274https://curecurrent.com/trials/examining-effects-of-ocrevus-on-cognitive-fatigue-using-fmri-104275https://curecurrent.com/trials/brain-imaging-and-immune-changes-during-remibrutinib-treatment-in-multiple-sclerosis-104276https://curecurrent.com/trials/pregnancy-exposure-registry-for-vumerity-diroximel-fumarate-104277https://curecurrent.com/trials/prospective-evaluation-of-de-escalation-from-anticd-20-therapies-to-dimethyl-fumarate-tecfidera-or-diroximel-fumarate-vu-104278https://curecurrent.com/trials/multiple-sclerosis-falls-insight-track-104279https://curecurrent.com/trials/examining-effects-of-tysabri-on-cognitive-fatigue-using-fmri-104280https://curecurrent.com/trials/pregnancy-registry-infants-serum-milk-analysis-prisma-104281https://curecurrent.com/trials/safety-and-efficacy-of-fingolimod-in-pediatric-patients-with-multiple-sclerosis-104282https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-svg103-paxalisib-in-focal-cortical-dysplasia-type-ii-fcd-ii-tuberous-scleros-104283https://curecurrent.com/trials/phase-ib-ii-study-of-sys6020-in-relapsing-refractory-multiple-sclerosis-104284https://curecurrent.com/trials/a-study-of-kyv-101-a-cd19-car-t-cell-therapy-in-participants-with-treatment-refractory-progressive-multiple-sclerosis-104285https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-a-new-maintenance-dosing-regimen-of-ofatumumab-104286https://curecurrent.com/trials/cladribine-tablets-level-of-response-predictors-in-clinical-practice-clodina-104287https://curecurrent.com/trials/feasibility-of-remote-exercise-training-for-hispanics-latinos-with-ms-104288https://curecurrent.com/trials/the-effect-of-a-probiotic-administration-as-an-add-on-treatment-in-multiple-sclerosis-104289https://curecurrent.com/trials/relating-genetic-and-environmental-risk-scores-to-multiple-sclerosis-susceptibility-104290https://curecurrent.com/trials/a-study-to-assess-bioequivalence-of-two-subcutaneous-sc-formulations-of-ocrelizumab-in-participants-with-multiple-sclero-104291https://curecurrent.com/trials/study-of-coya-302-for-the-treatment-of-als-104292https://curecurrent.com/trials/mental-rotation-and-motor-imagery-training-in-multiple-sclerosis-104293https://curecurrent.com/trials/application-of-ihmt-mri-in-multiple-sclerosis-104294https://curecurrent.com/trials/acute-effects-of-walking-exercise-on-brain-functioning-in-multiple-sclerosis-104295https://curecurrent.com/trials/autism-spectrum-disorder-asd-and-intellectual-disability-id-determinants-in-tuberous-sclerosis-complex-tsc-104296https://curecurrent.com/trials/webcams-walking-exercise-for-brain-and-cognition-in-adults-with-multiple-sclerosis-104297https://curecurrent.com/trials/a-novel-combinatory-approach-to-maximize-functional-recovery-of-learning-and-memory-in-multiple-sclerosis-104298https://curecurrent.com/trials/electrical-brain-stimulation-for-treatment-of-secondary-symptoms-in-multiple-sclerosis-104299https://curecurrent.com/trials/safety-and-efficacy-of-s103-cells-in-progressive-refractory-multiple-sclerosis-104300https://curecurrent.com/trials/effect-of-sensory-integration-therapy-on-gait-variability-and-quality-of-life-in-patients-with-multiple-sclerosis-104301https://curecurrent.com/trials/cognitive-disability-and-quality-of-life-of-patients-suffering-from-multiple-sclerosis-and-treatment-with-immunosuppress-104302https://curecurrent.com/trials/a-study-to-asses-efficacy-safety-and-tolerability-of-monthly-long-acting-im-injection-of-ga-depot-in-subjects-with-rms-104303https://curecurrent.com/trials/this-study-involves-a-positron-emission-tomography-pet-scan-using-a-new-investigational-radioactive-tracer-18f-fzta-to-d-104304https://curecurrent.com/trials/a-study-to-evaluate-efficacy-safety-and-tolerability-of-alemtuzumab-in-pediatric-patients-with-rrms-with-disease-activit-104305https://curecurrent.com/trials/cognition-evolution-and-mri-markers-in-ppms-patients-on-2-years-104306https://curecurrent.com/trials/a-study-of-treatment-patterns-and-annualized-relapse-rate-in-multiple-sclerosis-patients-who-escalate-versus-continue-di-104307https://curecurrent.com/trials/online-mindfulness-based-cognitive-therapy-for-people-with-multiple-sclerosis-with-mild-moderate-depression-104308https://curecurrent.com/trials/effectiveness-of-a-mindfulness-based-intervention-for-pain-management-in-patients-with-multiple-sclerosis-mpims-104309https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-efficacy-and-drug-levels-of-cc-97540-in-participants-with-relapsing-forms-of-104310https://curecurrent.com/trials/understanding-and-enhancing-human-health-and-movement-104311https://curecurrent.com/trials/immersive-virtual-reality-and-exercise-programs-in-multiple-sclerosis-exerviem-iii-104312https://curecurrent.com/trials/effect-of-low-histamine-based-modified-mediterranean-diet-in-multiple-sclerosis-104313https://curecurrent.com/trials/relationship-between-single-and-dual-task-obstacle-crossing-performance-and-fatigue-and-disability-in-multiple-sclerosis-104314https://curecurrent.com/trials/characterizing-the-use-of-ofatumumab-in-a-real-world-setting-104315https://curecurrent.com/trials/a-study-of-oxidative-pathways-in-ms-fatigue-104316https://curecurrent.com/trials/a-nis-evaluating-various-injectable-and-oral-treatments-in-patients-with-relapsing-multiple-sclerosis-104317https://curecurrent.com/trials/sociocognitive-intervention-and-rehabilitation-program-in-multiple-sclerosis-104318https://curecurrent.com/trials/risk-of-progressive-multifocal-leukoencephalopathy-among-patients-with-multiple-sclerosis-exposed-to-zeposia-104319https://curecurrent.com/trials/educational-programs-based-on-healthy-habits-to-improve-quality-of-life-and-psychosocial-profile-in-women-with-neurodege-104320https://curecurrent.com/trials/effects-of-sensorimotor-insoles-on-stability-and-gait-in-patients-with-multiple-sclerosis-104321https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-remibrutinib-in-secondary-progressive-multiple-sclerosis-104322https://curecurrent.com/trials/exploration-of-novel-imaging-biomarkers-on-oct-for-ublituximab-treatment-response-in-multiple-sclerosis-104323https://curecurrent.com/trials/a-rollover-study-to-evaluate-the-long-term-safety-and-efficacy-of-ocrelizumab-in-patients-with-multiple-sclerosis-104324https://curecurrent.com/trials/sacral-neuromodulation-for-neurogenic-lower-urinary-tract-bowel-and-sexual-dysfunction-104325https://curecurrent.com/trials/biomarkers-in-autoimmune-disease-of-nervous-system-104326https://curecurrent.com/trials/physical-activity-intervention-for-individuals-newly-diagnosed-with-ms-104327https://curecurrent.com/trials/cladribine-tablets-collaborative-study-to-evaluate-impact-on-central-nervous-system-biomarkers-in-multiple-sclerosis-104328https://curecurrent.com/trials/accuracy-of-motor-performance-perception-in-multiple-sclerosis-104329https://curecurrent.com/trials/sertraline-vs-placebo-in-the-treatment-of-anxiety-in-children-and-adolescents-with-neurodevelopmental-disorders-104330https://curecurrent.com/trials/immersive-virtual-reality-and-exercise-programs-in-multiple-sclerosis-104331https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-pk-of-a-higher-dose-of-ocrelizumab-in-adults-with-primary-p-104332https://curecurrent.com/trials/effects-of-ctar-and-pnf-exercises-on-swallowing-in-multiple-sclerosis-104333https://curecurrent.com/trials/single-arm-trial-identifying-barriers-and-facilitators-to-mindfulness-practice-104334https://curecurrent.com/trials/a-study-to-evaluate-ocrelizumab-treatment-in-participants-with-progressive-multiple-sclerosis-104335https://curecurrent.com/trials/combating-age-related-failure-of-myelination-in-multiple-sclerosis-an-exploratory-study-104336https://curecurrent.com/trials/early-behavioral-intervention-to-improve-social-communication-function-in-infants-with-tuberous-sclerosis-complex-104337https://curecurrent.com/trials/effects-of-powered-hip-flexion-device-in-persons-with-multiple-sclerosis-104338https://curecurrent.com/trials/turkish-version-of-the-neurogenic-bladder-symptom-score-short-form-104339https://curecurrent.com/trials/phenogene-1a-cromolyn-treatment-in-patients-with-mild-to-moderate-als-104340https://curecurrent.com/trials/evaluation-of-a-theory-driven-manualized-approach-to-improving-new-learning-and-memory-in-ms-104341https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-vt7208-in-healthy-participants-and-ms-patients-104342https://curecurrent.com/trials/bright-light-therapy-for-sleep-disturbance-in-people-with-multiple-sclerosis-104343https://curecurrent.com/trials/study-to-evaluate-the-usability-and-value-of-integrated-digital-solutions-in-medical-care-of-participants-with-multiple-104344https://curecurrent.com/trials/efficacy-and-safety-studies-of-frexalimab-sar441344-in-adults-with-relapsing-forms-of-multiple-sclerosis-104345https://curecurrent.com/trials/dalfampridine-combined-with-physical-therapy-for-mobility-impairment-in-multiple-sclerosis-104346https://curecurrent.com/trials/tibulizumab-systemic-sclerosis-understanding-and-response-evaluation-tibusure-104347https://curecurrent.com/trials/safety-extension-study-of-oral-edaravone-administered-in-subjects-with-amyotrophic-lateral-sclerosis-als-104348https://curecurrent.com/trials/effects-of-chiropractic-care-on-cytokine-levels-in-multiple-sclerosis-104349https://curecurrent.com/trials/ocrevus-zunovo-for-ms-mixed-methods-104350https://curecurrent.com/trials/targeting-agonists-of-glucagon-like-peptide-1-receptor-for-multiple-sclerosis-104351https://curecurrent.com/trials/effects-of-motor-imagery-and-sensorimotor-training-104352https://curecurrent.com/trials/mechanisms-of-cannabidiol-in-persons-with-ms-the-role-of-sleep-and-pain-phenotype-104353https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-cellular-kinetics-and-pharmacodynamics-of-p-cd19cd20-allo1-in-participants-w-104354https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-ocrelizumab-in-comparison-with-fingolimod-in-children-and-adolescents-with-re-104355https://curecurrent.com/trials/early-prediction-of-outcomes-following-optic-neuritis-development-and-acceptability-of-a-prognostic-tool-104356https://curecurrent.com/trials/validation-and-standardization-of-paramagnetic-rim-lesion-prl-identification-in-multiple-sclerosis-across-magnims-center-104357https://curecurrent.com/trials/effects-of-antiviral-therapies-on-epstein-barr-virus-replication-104358https://curecurrent.com/trials/ofsep-very-high-definition-cohort-104359https://curecurrent.com/trials/a-comparative-study-of-pharmacokinetics-pharmacodynamics-safety-and-immunogenicity-of-rph-035-and-ocrevus-in-patients-wi-104360https://curecurrent.com/trials/ofsep-high-definition-cohort-104361https://curecurrent.com/trials/exercise-rehabilitation-program-in-ms-who-use-wheelchairs-as-a-primary-mobility-device-104362https://curecurrent.com/trials/switch-to-ofatumumab-and-level-of-immunoglobulins-104363https://curecurrent.com/trials/opm-meg-in-non-immune-and-immune-mediated-neurological-disease-104364https://curecurrent.com/trials/evaluation-of-usability-and-safety-of-the-self-balancing-walking-system-atalante-in-patients-with-multiple-sclerosis-104365https://curecurrent.com/trials/wearables-for-the-bladder-an-in-home-treatment-feasibility-pilot-study-104366https://curecurrent.com/trials/ofatumumab-in-portuguese-multiple-sclerosis-patients-an-observational-study-104367https://curecurrent.com/trials/hybrid-assistive-limb-application-in-multiple-sclerosis-patients-104368https://curecurrent.com/trials/effects-of-home-based-respiratory-muscle-training-with-new-load-adjustment-test-in-people-with-multiple-sclerosis-104369https://curecurrent.com/trials/the-united-kingdom-multiple-sclerosis-register-covid-19-substudy-104370https://curecurrent.com/trials/promotion-of-exercise-through-physical-therapy-for-multiple-sclerosis-a-pilot-study-104371https://curecurrent.com/trials/wrist-position-sense-in-individuals-with-multiple-sclerosis-104372https://curecurrent.com/trials/study-to-investigate-vagus-nerve-stimulation-paired-with-motor-task-for-remyelination-and-functional-recovery-104373https://curecurrent.com/trials/functional-balance-intervention-in-multiple-sclerosis-104374https://curecurrent.com/trials/an-observational-study-to-learn-about-the-interferon-beta-exposure-of-pregnant-women-during-the-second-and-third-trimest-104375https://curecurrent.com/trials/the-impact-of-good-versus-poor-sleep-quality-on-quality-of-life-depression-and-fatigue-in-individuals-with-multiple-scle-104376https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-fatigue-mood-and-cognition-in-multiple-sclerosis-104377https://curecurrent.com/trials/study-of-home-use-of-the-jaco-robotic-manipulation-device-by-individuals-with-tetraplegia-104378https://curecurrent.com/trials/assessing-changes-in-multi-parametric-mri-in-ms-patients-taking-clemastine-fumarate-as-a-myelin-repair-therapy-104379https://curecurrent.com/trials/a-study-of-nasal-foralumab-in-non-active-secondary-progressive-multiple-sclerosis-patients-104380https://curecurrent.com/trials/the-effect-of-internal-or-external-focused-exercise-training-administered-in-conjunction-with-a-cognitive-task-on-walkin-104381https://curecurrent.com/trials/effects-of-task-oriented-training-on-functional-mobility-and-fatigue-in-patients-with-multiple-sclerosis-104382https://curecurrent.com/trials/a-study-of-c-car168-in-the-treatment-of-autoimmune-diseases-refractory-to-standard-therapy-104383https://curecurrent.com/trials/inspiratory-muscle-training-in-individuals-with-multiple-sclerosis-104384https://curecurrent.com/trials/home-based-spinal-cord-stimulation-for-hand-arm-function-in-ms-104385https://curecurrent.com/trials/rd06-05-universal-cd19-bcma-car-t-for-refractory-pediatric-autoimmune-diseases-104386https://curecurrent.com/trials/active-and-mindful-a-mind-body-programme-for-people-with-multiple-sclerosis-a-feasibility-study-protocol-104387https://curecurrent.com/trials/home-based-transcranial-direct-current-stimulation-tdcs-for-depression-in-multiple-sclerosis-ms-104388https://curecurrent.com/trials/mri-hippocampal-microstructure-and-episodic-memory-in-early-multiple-sclerosis-104389https://curecurrent.com/trials/safety-and-efficacy-study-of-fingolimod-in-taiwanese-adults-20years-with-relapsing-remitting-multiple-sclerosis-104390https://curecurrent.com/trials/effects-of-a-dual-task-intervention-in-postural-control-in-multiple-sclerosis-patients-104391https://curecurrent.com/trials/periodontal-disease-in-rare-renal-disorders-perio-ra-re-104392https://curecurrent.com/trials/reset-ms-a-study-to-evaluate-the-safety-and-efficacy-of-caba-201-in-participants-with-multiple-sclerosis-104393https://curecurrent.com/trials/comprehensive-rehabilitation-programme-in-people-with-multiple-sclerosis-the-reconnect-ms-study-104394https://curecurrent.com/trials/peer-support-impact-on-therapeutic-adherence-in-patients-with-multiple-sclerosis-104395https://curecurrent.com/trials/balance-gait-and-motion-analysis-in-multiple-sclerosis-104396https://curecurrent.com/trials/treatment-of-renal-angiomyolipomas-in-tuberous-sclerosis-by-beta-blockers-104397https://curecurrent.com/trials/tsc-biosample-repository-and-natural-history-database-104398https://curecurrent.com/trials/a-study-of-lcar-aio-car-t-cells-for-treating-relapsed-refractory-neurological-autoimmune-diseases-104399https://curecurrent.com/trials/a-prospective-randomized-non-inferiority-trial-comparing-anti-cd20-maintenance-versus-de-escalation-strategy-in-relapsin-104400https://curecurrent.com/trials/tai-chi-and-square-stepping-exercises-in-women-with-multiple-sclerosis-104401https://curecurrent.com/trials/gait-adaptation-study-104402https://curecurrent.com/trials/monthly-monitoring-of-plasma-nfl-in-treated-relapsing-remitting-multiple-sclerosis-to-detect-persistent-infraclinical-di-104403https://curecurrent.com/trials/motor-learning-of-fall-resistant-skills-through-slip-and-trip-exposure-in-multiple-sclerosis-104404https://curecurrent.com/trials/cohort-study-on-neuroimmune-diseases-in-the-reproductive-age-104405https://curecurrent.com/trials/effects-of-ocrevus-in-relapsing-multiple-sclerosis-104406https://curecurrent.com/trials/diagnostic-value-of-evog-104407https://curecurrent.com/trials/spinal-alignment-spinal-mobility-and-balance-in-patients-with-multiple-sclerosis-104408https://curecurrent.com/trials/longitudinal-cortical-demyelination-in-multiple-sclerosis-and-related-disorders-104409https://curecurrent.com/trials/impact-study-of-2-therapeutic-strategy-for-aggressive-remitting-multiple-sclerosis-104410https://curecurrent.com/trials/emisep-early-spinal-cord-lesions-and-late-disability-in-relapsing-remitting-multiple-sclerosis-patients-104411https://curecurrent.com/trials/clinical-and-imaging-cohort-of-neuroinflammation-diseases-in-china-clue-104412https://curecurrent.com/trials/primus-real-world-usage-for-real-world-evidence-of-cdss-use-in-multiple-sclerosis-104413https://curecurrent.com/trials/effect-of-high-intensity-focused-electromagnetic-therapy-on-balance-and-quality-of-life-in-patients-with-multiple-sclero-104414https://curecurrent.com/trials/a-study-to-evaluate-the-real-world-experience-and-satisfaction-associated-with-ofatumumab-104415https://curecurrent.com/trials/a-study-to-investigate-multiple-sclerosis-relapse-prevention-with-mrna-1195-compared-with-placebo-in-participants-aged-1-104416https://curecurrent.com/trials/ms-and-health-cohort-104417https://curecurrent.com/trials/effects-of-low-load-blood-flow-restriction-exercise-on-rectus-femoris-muscle-morphology-in-individuals-with-relapsing-re-104418https://curecurrent.com/trials/impact-of-multiple-sclerosis-from-the-viewpoint-of-the-patients-and-their-caregivers-104419https://curecurrent.com/trials/efficacy-of-cognitive-behavioral-therapy-for-insomnia-to-treat-insomnia-symptoms-in-individuals-with-multiple-sclerosis-104420https://curecurrent.com/trials/tear-analysis-in-the-diagnosis-of-multiple-sclerosis-104421https://curecurrent.com/trials/telesm-edu-nursing-a-personalised-nursing-intervention-for-people-with-multiple-sclerosis-104422https://curecurrent.com/trials/kesimpta-ofatumumab-in-greek-multiple-sclerosis-patients-an-observational-study-104423https://curecurrent.com/trials/retinal-atrophy-and-neurofilament-light-chain-in-people-with-multiple-sclerosis-taking-ofatumumab-104424https://curecurrent.com/trials/effects-of-aerobic-and-resistance-training-on-immune-function-in-multiple-sclerosis-104425https://curecurrent.com/trials/b-cell-tailored-ocrelizumab-versus-standard-ocrelizumab-in-relapsing-remitting-multiple-sclerosis-104426https://curecurrent.com/trials/effect-of-visually-guided-gait-training-on-balance-mobility-and-risk-of-falling-in-patients-with-multiple-sclerosis-104427https://curecurrent.com/trials/the-italian-multiple-sclerosis-and-related-disorders-register-104428https://curecurrent.com/trials/solriamfetol-for-the-treatment-of-multiple-sclerosis-fatigue-104429https://curecurrent.com/trials/my-ms-toolkit-an-internet-based-depression-self-management-program-for-adults-living-with-multiple-sclerosis-104430https://curecurrent.com/trials/atlg-levels-in-autologous-hsct-for-multiple-sclerosis-104431https://curecurrent.com/trials/low-load-resistance-training-using-blood-flow-restriction-for-people-with-multiple-sclerosis-104432https://curecurrent.com/trials/effect-of-probiotics-on-relapsing-remitting-multiple-sclerosis-104433https://curecurrent.com/trials/acute-intermittent-hypoxia-combined-with-gait-training-in-multiple-sclerosis-104434https://curecurrent.com/trials/peptide-coupled-red-blood-cells-for-the-treatment-of-multiple-sclerosis-104435https://curecurrent.com/trials/hyperpolarized-carbon-metabolic-imaging-in-multiple-sclerosis-104436https://curecurrent.com/trials/measuring-blood-vessel-density-in-the-optic-nerve-of-multiple-sclerosis-patients-with-octa-104437https://curecurrent.com/trials/single-and-multiple-ascending-dose-study-of-mtr-601-in-healthy-individuals-104438https://curecurrent.com/trials/pathological-basis-of-mri-signal-changes-in-multiple-sclerosis-104439https://curecurrent.com/trials/the-energetic-origin-of-neurodegeneration-in-ms-104440https://curecurrent.com/trials/central-nervous-system-uptake-of-anti-cd8-t-cell-minibodies-in-multiple-sclerosis-and-progressive-multifocal-leukoenceph-104441https://curecurrent.com/trials/intermittent-low-oxygen-breathing-a-first-study-testing-different-disease-stages-in-people-living-with-ms-104442https://curecurrent.com/trials/examining-the-effects-of-a-remotely-delivered-racially-tailored-exercise-training-program-for-immediate-and-sustained-im-104443https://curecurrent.com/trials/exercise-training-for-managing-major-depressive-disorder-in-multiple-sclerosis-104444https://curecurrent.com/trials/a-study-to-learn-more-about-the-safety-of-diroximel-fumarate-vumerity-in-participants-who-took-it-during-pregnancy-and-a-104445https://curecurrent.com/trials/epidyolex-in-lennox-gastaut-dravet-syndrome-and-tuberous-sclerosis-complex-an-observational-study-in-italy-104446https://curecurrent.com/trials/behavioral-and-electrophysiological-evidence-of-the-modulation-of-fatigue-in-rr-ms-104447https://curecurrent.com/trials/the-use-of-technology-to-improve-ms-clinical-trials-and-patient-care-104448https://curecurrent.com/trials/effects-of-selexipag-in-adults-with-raynaud-s-phenomenon-secondary-to-systemic-sclerosis-104449https://curecurrent.com/trials/internet-delivered-lifestyle-physical-activity-intervention-for-cognitive-processing-speed-in-multiple-sclerosis-104450https://curecurrent.com/trials/t-cell-profiling-in-patients-with-multiple-sclerosis-104451https://curecurrent.com/trials/telerehabilitation-based-motor-imagery-and-action-observation-training-in-multiple-sclerosis-104452https://curecurrent.com/trials/tracking-peripheral-immune-cell-infiltration-of-the-brain-in-central-inflammatory-disorders-using-zr-89-oxinate-4-labele-104453https://curecurrent.com/trials/exploratory-pilot-study-on-the-prolonged-use-of-the-able-exoskeleton-in-multiple-sclerosis-104454https://curecurrent.com/trials/assessment-of-neuroinflammation-in-central-inflammatory-disorders-using-f-18-dpa-714-104455https://curecurrent.com/trials/effects-of-sleep-quality-on-functional-and-cognitive-outcomes-in-multiple-sclerosis-104456https://curecurrent.com/trials/mri-based-lesion-differentiation-in-older-patients-with-multiple-sclerosis-104457https://curecurrent.com/trials/stratification-of-risks-of-conversion-of-radiologically-isolated-syndromes-ris-by-identifying-biomarkers-in-serum-and-ce-104458https://curecurrent.com/trials/a-study-to-describe-the-persistence-with-ozanimod-treatment-in-relapsing-remitting-multiple-sclerosis-rrms-participants-104459https://curecurrent.com/trials/silodosin-for-urinary-symptoms-in-female-patients-with-multiple-sclerosis-104460https://curecurrent.com/trials/comparative-pk-pd-efficacy-and-safety-assessment-of-the-proposed-ocrelizumab-biosimilar-cyb704-and-ocrevus-in-participan-104461https://curecurrent.com/trials/lemtrada-pregnancy-registry-in-multiple-sclerosis-104462https://curecurrent.com/trials/a-multicenter-study-of-continued-current-therapy-vs-transition-to-ofatumumab-after-neurofilament-nfl-elevation-104463https://curecurrent.com/trials/study-evaluating-kesimpta-treatment-effects-in-patients-with-relapsing-multiple-sclerosis-transitioning-from-other-thera-104464https://curecurrent.com/trials/dry-needling-in-multiple-sclerosis-104465https://curecurrent.com/trials/noninvasive-vagal-nerve-stimulation-104466https://curecurrent.com/trials/exercise-balance-program-for-fall-prevention-in-multiple-sclerosis-104467https://curecurrent.com/trials/ketamine-for-multiple-sclerosis-fatigue-104468https://curecurrent.com/trials/a-biosimilar-trial-to-investigate-pk-pd-safety-with-pb018-versus-us-licensed-ocrevus-and-eu-approved-ocrevus-104469https://curecurrent.com/trials/evaluating-the-immune-response-to-covid19-vaccination-in-immunodeficient-patients-104470https://curecurrent.com/trials/deciphering-preserved-autonomic-function-after-multiple-sclerosis-104471https://curecurrent.com/trials/efficacy-and-safety-study-of-myobloc-in-the-treatment-of-adult-upper-limb-spasticity-104472https://curecurrent.com/trials/long-term-safety-tolerability-and-effectiveness-study-of-ofatumumab-in-patients-with-relapsing-ms-104473https://curecurrent.com/trials/cut-off-values-for-gait-and-balance-in-ms-104474https://curecurrent.com/trials/this-is-an-early-exploratory-study-to-assess-the-tolerability-and-safety-of-gc012f-in-patients-with-multiple-sclerosis-104475https://curecurrent.com/trials/essential-oils-for-urinary-symptoms-in-multiple-sclerosis-patients-104476https://curecurrent.com/trials/cognition-and-mri-markers-in-ms-patients-with-aubagio-treatment-104477https://curecurrent.com/trials/acceptability-of-exoskeleton-assisted-walking-for-persons-with-mobility-issues-due-to-multiple-sclerosis-104478https://curecurrent.com/trials/phase-3-efficacy-and-safety-study-of-bg00012-in-pediatric-participants-with-relapsing-remitting-multiple-sclerosis-rrms-104479https://curecurrent.com/trials/impact-of-mayzent-on-aspms-patients-in-a-long-term-nis-in-italy-104480https://curecurrent.com/trials/tms-combined-with-virtual-reality-and-multidisciplinary-rehabilitation-in-multiple-sclerosis-104481https://curecurrent.com/trials/serum-auto-antibodies-in-neurological-diseases-104482https://curecurrent.com/trials/visual-path-ways-in-multiple-sclerosis-part-ii-104483https://curecurrent.com/trials/a-study-evaluating-the-safety-and-tolerability-of-qrl-201-in-als-104484https://curecurrent.com/trials/impact-of-ttns-on-bladder-symptoms-among-people-with-ms-a-rct-104485https://curecurrent.com/trials/healthy-eating-and-active-living-for-people-living-with-multiple-sclerosis-heal-ms-a-lifestyle-program-for-people-with-m-104486https://curecurrent.com/trials/elios-investigational-biomarkers-to-track-disease-modification-in-active-rrms-104487https://curecurrent.com/trials/cd19-bcma-ucar-t-for-b-cell-related-autoimmune-disease-104488https://curecurrent.com/trials/genes-and-environment-in-multiple-sclerosis-104489https://curecurrent.com/trials/efficacy-and-safety-study-of-frexalimab-sar441344-in-adults-with-nonrelapsing-secondary-progressive-multiple-sclerosis-104490https://curecurrent.com/trials/validation-of-brief-computerized-cognitive-assessment-in-multiple-sclerosis-bccams-104491https://curecurrent.com/trials/study-of-social-cognition-by-morphological-and-functional-imaging-in-multiple-sclerosis-patients-104492https://curecurrent.com/trials/plasma-exchanges-in-multiple-sclerosis-ms-relapses-104493https://curecurrent.com/trials/efficacy-and-safety-of-ofatumumab-and-siponimod-compared-to-fingolimod-in-pediatric-patients-with-multiple-sclerosis-104494https://curecurrent.com/trials/a-study-utilising-data-from-european-union-eu-national-multiple-sclerosis-ms-registries-to-assess-the-incidence-of-anti-104495https://curecurrent.com/trials/multiple-sclerosis-futurems-2-an-observational-cohort-and-scottish-precision-medicine-study-104496https://curecurrent.com/trials/platform-trial-to-assess-the-efficacy-of-multiple-drugs-in-amyotrophic-lateral-sclerosis-als-104497https://curecurrent.com/trials/octive-a-new-horizon-in-ms-digital-solution-104498https://curecurrent.com/trials/auditory-functions-in-patients-with-multiple-sclerosis-104499https://curecurrent.com/trials/gait-adaptability-in-persons-with-ms-having-mild-disability-104500https://curecurrent.com/trials/safety-and-pharmacodynamics-of-qh103-cell-injection-in-the-treatment-of-patients-with-relapsed-refractory-antibody-media-104501https://curecurrent.com/trials/olfactory-and-trigeminal-functions-in-patients-with-multiple-sclerosis-case-control-study-104502https://curecurrent.com/trials/cd19-bcma-targeted-ucar-t-for-patients-with-neurological-autoimmune-diseases-104503https://curecurrent.com/trials/efficacy-of-l-carnitine-versus-placebo-in-the-treatment-of-fatigue-in-multiple-sclerosis-104504https://curecurrent.com/trials/a-real-world-study-comparing-the-effectiveness-of-ofatumumab-and-ocrelizumab-treatment-in-multiple-sclerosis-patients-104505https://curecurrent.com/trials/fall-prevention-among-people-with-spinal-cord-injury-and-multiple-sclerosis-who-use-wheelchairs-and-scooters-104506https://curecurrent.com/trials/prevalence-and-impact-of-obstructive-sleep-apnea-in-multiple-sclerosis-104507https://curecurrent.com/trials/mb-cart2019-1-in-refractory-multiple-sclerosis-104508https://curecurrent.com/trials/nomad-p-kafo-study-104509https://curecurrent.com/trials/predicting-disease-activity-and-rebound-risk-in-ms-patients-treated-with-sphingosine-1-phosphate-receptor-modulators-s1p-104510https://curecurrent.com/trials/glymphatic-mri-in-clinically-isolated-syndrome-104511https://curecurrent.com/trials/cognitive-motor-telerehabilitation-in-ms-104512https://curecurrent.com/trials/internuclear-ophthalmoplegia-and-multiple-sclerosis-a-multicenter-retrospective-study-104513https://curecurrent.com/trials/effects-of-high-intensity-gait-training-on-fatigue-gait-and-neuroplasticity-in-people-with-multiple-sclerosis-104514https://curecurrent.com/trials/gait-in-rare-diseases-104515https://curecurrent.com/trials/safety-and-efficacy-of-extracorporeal-photopheresis-ecp-in-the-treatment-of-multiple-sclerosis-104516https://curecurrent.com/trials/dual-task-training-in-pediatric-multiple-sclerosis-104517https://curecurrent.com/trials/the-effect-of-dns-based-training-combined-with-pfmt-on-luts-and-pelvic-floor-functions-in-women-with-ms-104518https://curecurrent.com/trials/masitinib-in-the-treatment-of-patients-with-primary-progressive-or-non-active-secondary-progressive-multiple-sclerosis-104519https://curecurrent.com/trials/conventional-vestibular-training-versus-immersive-virtual-reality-based-vestibular-in-multiple-sclerosis-104520https://curecurrent.com/trials/study-of-ublituximab-for-ocrelizumab-wearing-off-in-multiple-sclerosis-104521https://curecurrent.com/trials/clemastine-fumarate-as-remyelinating-treatment-in-internuclear-ophthalmoparesis-and-multiple-sclerosis-104522https://curecurrent.com/trials/reduced-oligodendrocyte-specific-cytotoxicity-and-ofatumumab-treatment-104523https://curecurrent.com/trials/care-in-multiple-sclerosis-ms-104524https://curecurrent.com/trials/effectiveness-of-home-based-exercise-and-brain-stimulation-for-reducing-fatigue-in-patients-with-multiple-sclerosis-104525https://curecurrent.com/trials/a-phase-iia-study-of-vitamin-d3-tolerogenic-dendritic-cells-toldc-for-multiple-sclerosis-104526https://curecurrent.com/trials/mixed-reality-for-upper-limb-rehabilitation-in-people-with-multiple-sclerosis-virtualdomus-104527https://curecurrent.com/trials/ecog-bmi-for-motor-and-speech-control-104528https://curecurrent.com/trials/augmented-reality-based-dual-task-training-in-people-with-multiple-sclerosis-104529https://curecurrent.com/trials/physical-telerehabilitation-in-veterans-with-multiple-sclerosis-104530https://curecurrent.com/trials/deployment-o-the-multidisciplinary-prospective-cohort-imminent-104531https://curecurrent.com/trials/phenotypic-and-functional-study-of-4bl-b-cells-in-multiple-sclerosis-ms-104532https://curecurrent.com/trials/mri-biomarkers-predictive-of-disability-progression-in-patients-with-multiple-sclerosis-104533https://curecurrent.com/trials/nutritional-status-and-muscle-function-in-ambulatory-multiple-sclerosis-patients-with-dysphagia-104534https://curecurrent.com/trials/role-of-microglial-activation-and-norepinephrine-transporter-abnormalities-in-pathogenesis-of-ms-related-fatigue-104535https://curecurrent.com/trials/immunoglobulin-deficiency-a-treatable-cause-of-fatigue-in-patients-with-multiple-sclerosis-ms-104536https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-depression-in-multiple-sclerosis-104537https://curecurrent.com/trials/a-smart-phone-application-to-improve-adoption-of-the-2024-kidney-disease-improving-global-outcomes-kdigo-chronic-kidney-104538https://curecurrent.com/trials/non-invasive-bci-controlled-assistive-devices-104539https://curecurrent.com/trials/the-effect-of-acupressure-on-multiple-sclerosis-patients-104540https://curecurrent.com/trials/combined-motor-imagery-and-vestibular-rehab-for-ms-104541https://curecurrent.com/trials/assessment-of-the-quality-of-life-of-multiple-sclerosis-patients-treated-with-ofatumumab-in-real-life-in-france-104542https://curecurrent.com/trials/blood-flow-restriction-for-upper-limb-rehabilitation-in-people-with-multiple-sclerosis-a-randomized-controlled-trial-bfr-104543https://curecurrent.com/trials/bilateral-anodal-cerebellar-tdcs-for-multidomain-dysfunctions-in-patients-with-multiple-sclerosis-104544https://curecurrent.com/trials/smoldering-inflammation-in-ms-104545https://curecurrent.com/trials/macromolecular-imaging-of-white-and-gray-matter-pathology-in-multiple-sclerosis-104546https://curecurrent.com/trials/a-study-to-investigate-behavioral-and-other-co-occurring-outcomes-with-epidiolex-as-add-on-therapy-in-participants-aged-104547https://curecurrent.com/trials/identification-of-retinal-perivascular-inflammation-in-patients-with-multiple-sclerosis-using-adaptive-optics-retimus-104548https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-pharmacokinetics-of-single-and-multiple-doses-of-prosetin-in-healthy-volunteers-and-p-104549https://curecurrent.com/trials/cognitive-musical-screening-and-therapeutic-innovation-in-multiple-sclerosis-104550https://curecurrent.com/trials/mitoq-for-fatigue-in-multiple-sclerosis-ms-104551https://curecurrent.com/trials/exercise-training-for-people-with-advanced-multiple-sclerosis-104552https://curecurrent.com/trials/caregiver-burden-in-caregivers-of-patients-with-multiple-sclerosis-104553https://curecurrent.com/trials/supporting-mental-health-in-daily-life-after-the-diagnosis-of-multiple-sclerosis-104554https://curecurrent.com/trials/safety-and-efficacy-of-monthly-long-acting-im-injection-of-25mg-or-40-mg-ga-depot-in-subjects-with-ppms-104555https://curecurrent.com/trials/the-effects-of-a-12-week-in-phase-bilateral-exercise-programme-on-the-corticospinal-plasticity-in-people-with-progressiv-104556https://curecurrent.com/trials/an-open-label-single-arm-clinical-study-to-evaluate-the-safety-and-preliminary-efficacy-of-cd20-monoclonal-antibody-comb-104557https://curecurrent.com/trials/multicenter-prospective-study-analyzing-the-occurrence-of-multiple-sclerosis-relapses-without-radiological-evidence-myth-104558https://curecurrent.com/trials/a-palliative-care-model-impact-on-knowledge-and-attitudes-104559https://curecurrent.com/trials/pens-vs-tens-for-hand-function-in-multiple-sclerosis-104560https://curecurrent.com/trials/conventional-multidisciplinary-gait-rehabilitation-vr-robotic-self-balancing-based-gait-rehabilitation-104561https://curecurrent.com/trials/fatigue-and-mental-well-being-in-ms-patients-multiple-sclerosis-104562https://curecurrent.com/trials/fatigue-in-ms-from-invisible-to-measurable-104563https://curecurrent.com/trials/invasive-home-ventilation-in-denmark-104564https://curecurrent.com/trials/nursing-students-brain-ms-immersive-three-dimensional-learning-activity-104565https://curecurrent.com/trials/definition-of-autonomic-nervous-system-involvement-in-patients-with-multiple-sclerosis-104566https://curecurrent.com/trials/genetic-and-electrophysiologic-study-in-focal-drug-resistant-epilepsies-104567https://curecurrent.com/trials/serum-gfap-nfl-vegf-and-clinical-progression-in-progressive-ms-104568https://curecurrent.com/trials/improving-cognitive-recovery-in-multiple-sclerosis-104569https://curecurrent.com/trials/effectiveness-of-cryotherapy-on-the-fatigue-of-patients-with-multiple-sclerosis-104570https://curecurrent.com/trials/exploratory-study-on-the-timing-of-multiple-sclerosis-ms-symptoms-104571https://curecurrent.com/trials/a-study-evaluating-b-cell-levels-in-infants-potentially-exposed-to-ocrelizumab-during-pregnancy-104572https://curecurrent.com/trials/kesimpta-ofatumumab-in-swiss-multiple-sclerosis-patients-an-observational-study-104573https://curecurrent.com/trials/amx0114-in-adult-participants-with-amyotrophic-lateral-sclerosis-104574https://curecurrent.com/trials/how-to-develop-the-highest-possible-leading-edge-interdisciplinary-care-model-for-people-with-ms-that-will-be-relevant-t-104575https://curecurrent.com/trials/a-study-on-the-safety-and-tolerability-of-universal-star-t-cell-therapy-for-multiple-sclerosis-104576https://curecurrent.com/trials/my-ms-and-my-menstrual-cycle-104577https://curecurrent.com/trials/comparison-of-frailty-physical-fitness-parameters-and-irisin-levels-between-patients-with-multiple-sclerosis-and-healthy-104578https://curecurrent.com/trials/itakos-italian-observation-multicenter-prospective-study-of-ofatumumab-in-rrms-patients-104579https://curecurrent.com/trials/rc18-in-patients-with-relapsing-remitting-multiple-sclerosis-a-phase-ii-trial-104580https://curecurrent.com/trials/vr-based-dexterity-training-in-ms-104581https://curecurrent.com/trials/impact-of-exercise-training-on-serum-glial-fibrillary-acidic-protein-gfap-brain-volumetry-and-functional-outcomes-in-mul-104582https://curecurrent.com/trials/walking-fatigability-saptiotemporal-gait-parameters-and-falling-in-ms-patients-104583https://curecurrent.com/trials/evaluation-of-the-effects-of-laughter-yoga-104584https://curecurrent.com/trials/an-open-label-study-evaluating-ofatumumab-treatment-effectiveness-and-pros-in-subjects-with-rms-transitioning-from-fumar-104585https://curecurrent.com/trials/impact-of-exercise-training-on-serum-neurofilament-light-chain-nfl-brain-volumetry-and-functional-outcomes-in-multiple-s-104586https://curecurrent.com/trials/medication-understanding-in-ms-104587https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-exploratory-efficacy-of-ims001-in-subjects-with-multiple-sclerosis-104588https://curecurrent.com/trials/extracorporeal-shock-wave-therapy-in-enhancing-sensitivity-and-postural-stability-in-multiple-sclerosis-104589https://curecurrent.com/trials/evaluation-of-a-self-management-program-to-prevent-falls-in-people-with-multiple-sclerosis-104590https://curecurrent.com/trials/computerized-cognitive-training-in-ms-104591https://curecurrent.com/trials/exopulse-suit-and-walking-ability-of-patients-with-multiple-sclerosis-104592https://curecurrent.com/trials/effectiveness-of-tms-on-spasticity-and-balance-for-patients-with-ms-104593https://curecurrent.com/trials/functional-outcomes-from-diets-in-multiple-sclerosis-104594https://curecurrent.com/trials/classification-of-upper-and-lower-limb-spasticity-patterns-and-their-impact-on-quality-of-life-in-patients-with-multiple-104595https://curecurrent.com/trials/evaluating-the-feasibility-and-effectiveness-of-an-online-psychological-intervention-targeting-problem-solving-and-copin-104596https://curecurrent.com/trials/allogeneic-cd19-bcma-car-t-for-b-cell-related-autoimmune-disease-104597https://curecurrent.com/trials/measurement-properties-of-the-walking-adaptability-ladder-test-and-foot-tap-test-in-multiple-sclerosis-104598https://curecurrent.com/trials/multiple-sclerosis-sarcopenia-and-respiration-104599https://curecurrent.com/trials/development-of-a-novel-functional-eye-tracking-software-application-for-multiple-sclerosis-104600https://curecurrent.com/trials/etna-ms-device-validation-study-104601https://curecurrent.com/trials/development-of-digital-biomarkers-in-multiple-sclerosis-validation-study-2-104602https://curecurrent.com/trials/astroscape-a-study-of-radiprodil-on-safety-tolerability-pharmacokinetics-and-effect-on-seizures-and-behavioral-symptoms-104603https://curecurrent.com/trials/investigating-eye-movement-biomarkers-of-disease-severity-and-cognition-in-multiple-sclerosis-104604https://curecurrent.com/trials/eye-tracking-investigation-of-clinical-measures-in-multiple-sclerosis-104605https://curecurrent.com/trials/evaluation-of-interoception-fatigue-and-upper-and-lower-extremity-functional-capacity-in-multiple-sclerosis-patients-wit-104606https://curecurrent.com/trials/safety-of-bryostatin-in-patients-with-ms-104607https://curecurrent.com/trials/this-is-an-open-label-study-to-assess-the-safety-and-efficacy-of-gc012f-in-patients-with-multiple-sclerosis-104608https://curecurrent.com/trials/skeletal-muscle-aging-and-responsiveness-in-aged-people-with-ms-104609https://curecurrent.com/trials/a-digital-therapeutic-to-improve-insomnia-in-multiple-sclerosis-a-randomized-controlled-trial-104610https://curecurrent.com/trials/vr-and-orthoses-for-rehabilitation-in-multiple-sclerosis-104611https://curecurrent.com/trials/disease-modifying-therapies-withdrawal-in-inactive-secondary-progressive-multiple-sclerosis-patients-older-than-50-years-104612https://curecurrent.com/trials/effects-of-mat-and-reformer-pilates-in-multiple-sclerosis-104613https://curecurrent.com/trials/a-self-management-program-to-prevent-falls-in-people-with-multiple-sclerosis-104614https://curecurrent.com/trials/the-prevalance-of-malnutrition-and-its-association-with-disability-in-patients-with-relapsing-remitting-multiple-scleros-104615https://curecurrent.com/trials/comparison-of-gait-metrics-in-patients-with-stroke-traumatic-brain-injury-and-multiple-sclerosis-104616https://curecurrent.com/trials/effects-of-ocrelizumab-treatment-on-immune-cells-in-lymph-nodes-in-multiple-sclerosis-104617https://curecurrent.com/trials/multiple-sclerosis-menstrual-cycle-and-physical-acivity-104618https://curecurrent.com/trials/comparison-of-the-performance-of-the-2024-and-2017-mcdonald-criteria-for-the-diagnosis-of-multiple-sclerosis-in-real-lif-104619https://curecurrent.com/trials/urinary-incontinence-and-pelvic-floor-muscle-activity-in-multiple-sclerosis-104620https://curecurrent.com/trials/identification-of-factors-related-to-ui-in-patients-with-ms-and-emg-assessment-of-pfm-activity-104621https://curecurrent.com/trials/obe-cel-in-refractory-progressive-forms-of-multiple-sclerosis-104622https://curecurrent.com/trials/investigating-specific-gait-patterns-in-individuals-living-with-multiple-sclerosis-104623https://curecurrent.com/trials/neuromodulating-cortical-regions-involved-in-neurogenic-bladder-in-ms-104624https://curecurrent.com/trials/investigating-the-impact-of-sex-hormones-in-multiple-sclerosis-104625https://curecurrent.com/trials/effects-of-pelvic-floor-strengthening-and-relaxation-exercises-in-women-diagnosed-with-multiple-sclerosis-104626https://curecurrent.com/trials/intermittent-hypoxia-in-persons-with-multiple-sclerosis-104627https://curecurrent.com/trials/a-novel-wearable-digital-biomarker-for-detecting-changes-in-multiple-sclerosis-ms-condition-104628https://curecurrent.com/trials/mhealth-effect-on-multiple-sclerosis-patients-quality-of-life-and-self-care-practices-104629https://curecurrent.com/trials/upper-limb-nerve-cryoneurolysis-is-non-inferior-to-the-usual-care-and-has-therapeutic-add-value-in-dealing-with-shoulder-104630https://curecurrent.com/trials/motor-asymmetry-in-progressive-multiple-sclerosis-patients-104631https://curecurrent.com/trials/a-study-to-evaluate-the-safety-efficacy-and-pharmacodynamics-of-pll001-in-als-patients-104632https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-diroximel-fumarate-drf-and-dimethyl-fumarate-dmf-and-their-effects-on-relapses-in-p-104633https://curecurrent.com/trials/ms-relapses-during-covid-19-pandemic-104634https://curecurrent.com/trials/from-genetics-to-transcriptomics-to-unravel-the-mechanisms-behind-a-poor-outcome-in-multiple-sclerosis-104635https://curecurrent.com/trials/prevalence-of-periodontitis-in-egyptian-multiple-sclerosis-patients-104636https://curecurrent.com/trials/remote-assessment-and-intervention-for-behavior-problems-in-kids-with-tsc-104637https://curecurrent.com/trials/the-effect-of-rituximab-on-cognitive-and-hand-functions-in-secondary-progressive-multiple-sclerosis-104638https://curecurrent.com/trials/ublituximab-briumvi-for-early-forms-of-relapsing-multiple-sclerosis-104639https://curecurrent.com/trials/effect-of-multimodal-exercise-training-in-patients-with-multiple-sclerosis-104640https://curecurrent.com/trials/effect-of-acetominophen-an-gait-fatigue-in-multiple-sclerosis-104641https://curecurrent.com/trials/effects-of-qigong-therapy-in-ms-patients-104642https://curecurrent.com/trials/factorial-optimization-trial-to-test-cognitive-behavioral-therapy-components-for-multiple-sclerosis-fatigue-104643https://curecurrent.com/trials/using-motor-imagery-based-brain-computer-interface-with-multiple-sclerosis-patients-104644https://curecurrent.com/trials/evaluation-of-early-changes-visible-to-the-diffusion-mri-in-response-to-two-years-of-treatment-with-tysabri-in-patients-104645https://curecurrent.com/trials/serious-game-rehabilitation-and-brain-plasticity-in-ms-104646https://curecurrent.com/trials/innovative-approaches-to-enhance-balance-and-neuroplasticity-in-multiple-sclerosis-104647https://curecurrent.com/trials/common-and-specific-information-from-neuroimaging-and-smartphone-104648https://curecurrent.com/trials/use-of-inertial-units-in-patient-with-multiple-sclerosis-imusep-104649https://curecurrent.com/trials/longitudinal-assessment-of-iron-rims-in-ms-lesions-104650https://curecurrent.com/trials/study-of-mesenchymal-autologous-stem-cells-as-regenerative-treatment-for-multiple-sclerosis-104651https://curecurrent.com/trials/consolidation-therapy-with-cladribine-in-relapsing-multiple-sclerosis-patients-104652https://curecurrent.com/trials/assessing-changes-in-multi-parametric-mri-in-patients-with-acute-demyelinating-lesions-taking-clemastine-fumarate-as-a-m-104653https://curecurrent.com/trials/impact-of-neuropsychological-disorders-in-multiple-sclerosis-104654https://curecurrent.com/trials/assessment-of-clemastine-fumarate-as-a-remyelinating-agent-in-acute-optic-neuritis-recover-104655https://curecurrent.com/trials/mechanisms-of-disease-severity-in-multiple-sclerosis-an-integrative-multimodal-study-104656https://curecurrent.com/trials/evaluation-of-a-spasticity-management-program-for-people-with-multiple-sclerosis-104657https://curecurrent.com/trials/neuroprotection-with-n-acetyl-cysteine-for-patients-with-progressive-multiple-sclerosis-104658https://curecurrent.com/trials/dreams-validation-study-1-104659https://curecurrent.com/trials/validity-and-reliability-of-timed-up-and-go-test-in-dual-task-conditions-for-multiple-sclerosis-patients-104660https://curecurrent.com/trials/implementation-of-an-app-based-walking-aid-skills-training-program-104661https://curecurrent.com/trials/effect-of-ocrelizumab-on-choroid-plexus-changes-in-patients-with-ppms-104662https://curecurrent.com/trials/a-study-of-ly4256984-in-participants-with-sporadic-amyotrophic-lateral-sclerosis-104663https://curecurrent.com/trials/evaluation-of-mn-166-ibudilast-for-12-months-followed-by-an-open-label-extension-for-6-months-in-patients-with-als-104664https://curecurrent.com/trials/wearable-focal-vibration-therapy-on-upper-extremity-function-of-people-with-multiple-sclerosis-a-pilot-study-104665https://curecurrent.com/trials/cognitive-performance-sleep-disturbances-and-fatigue-in-multiple-sclerosis-104666https://curecurrent.com/trials/exploring-cortical-remyelination-in-children-with-multiple-sclerosis-104667https://curecurrent.com/trials/study-of-neuroinflammation-in-multiple-sclerosis-by-pet-mri-imaging-using-the-radiotracer-18f-dpa-714-a-multicentre-coho-104668https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-amisodin-in-healthy-adult-subjects-with-amyotrophic-latera-104669https://curecurrent.com/trials/clinical-and-urodynamic-assessment-of-bladder-sensation-in-multiple-sclerosis-104670https://curecurrent.com/trials/hesperidin-rct-in-ms-104671https://curecurrent.com/trials/impact-of-adding-cognitive-behaviour-therapy-to-supervised-pilates-based-core-stability-training-in-patients-with-multip-104672https://curecurrent.com/trials/spinal-cord-lesion-detection-in-multiple-sclerosis-using-novel-mri-sequences-104673https://curecurrent.com/trials/motor-neurone-disease-systematic-multi-arm-adaptive-randomised-trial-104674https://curecurrent.com/trials/open-label-randomized-multicenter-to-assess-efficacy-tolerability-of-ofatumumab-20mg-vs-first-line-dmt-in-rms-104675https://curecurrent.com/trials/exercise-with-and-without-cognitive-training-104676https://curecurrent.com/trials/adas-to-alemtuzumab-104677https://curecurrent.com/trials/autologous-stem-cell-transplant-for-neurologic-autoimmune-diseases-104678https://curecurrent.com/trials/study-to-assess-the-effect-of-ofatumumab-in-treatment-na-ve-very-early-rrms-patients-benchmarked-against-healthy-control-104679https://curecurrent.com/trials/a-study-of-anti-cd19-chimeric-antigen-receptor-t-cell-car-t-therapy-in-subjects-with-non-relapsing-and-progressive-forms-104680https://curecurrent.com/trials/non-invasive-brain-stimulation-in-multiple-sclerosis-fatigue-104681https://curecurrent.com/trials/determine-pk-profiles-of-ozanimod-and-its-major-metabolites-in-healthy-subjects-104682https://curecurrent.com/trials/home-based-exergame-rehabilitation-for-upper-limb-function-in-people-with-multiple-sclerosis-104683https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ocrelizumab-in-adults-with-primary-progressive-multiple-sclerosis-104684https://curecurrent.com/trials/effects-of-acute-intermittent-hypoxia-on-neuroplasticity-in-ms-104685https://curecurrent.com/trials/the-synergistic-effects-of-aih-and-fes-in-persons-with-ms-104686https://curecurrent.com/trials/blood-flow-restriction-and-veterans-with-ms-104687https://curecurrent.com/trials/amygdala-insula-retraining-in-the-management-of-multiple-sclerosis-symptoms-104688https://curecurrent.com/trials/relationship-between-pelvic-floor-dysfunctions-and-lower-limb-strength-and-activation-in-ms-patients-104689https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-biib091-and-its-effect-on-brain-inflammation-when-taken-alone-or-with-diroximel-fum-104690https://curecurrent.com/trials/safety-and-efficacy-of-melatonin-in-patients-with-multiple-progressive-primary-sclerosis-104691https://curecurrent.com/trials/central-vein-sign-in-multiple-sclerosis-extension-study-104692https://curecurrent.com/trials/lead-exposure-and-multiple-sclerosis-104693https://curecurrent.com/trials/dendritic-cells-therapy-combined-with-immunomodulatory-treatment-in-multiple-sclerosis-104694https://curecurrent.com/trials/the-effects-of-face-to-face-and-tele-nursing-education-on-fatigue-pain-sleep-and-urinary-tract-infections-in-patients-wi-104695https://curecurrent.com/trials/study-of-the-mechanisms-of-action-of-cladribine-in-multiple-sclerosis-104696https://curecurrent.com/trials/an-extension-study-to-assess-impact-of-multiple-sclerosis-ms-on-physical-function-and-provide-continued-ocrelizumab-trea-104697https://curecurrent.com/trials/non-interventional-study-of-ocrelizumab-in-participants-with-relapsing-or-primary-progressive-multiple-sclerosis-104698https://curecurrent.com/trials/mastication-cognition-and-nutritional-status-in-multiple-sclerosis-104699https://curecurrent.com/trials/periodontal-health-profile-in-multiple-sclerosis-patients-104700https://curecurrent.com/trials/multiple-sclerosis-implementation-network-registry-104701https://curecurrent.com/trials/assessment-of-attentional-and-executive-disorders-in-multiple-sclerosis-using-techniques-of-virtual-reality-104702https://curecurrent.com/trials/brainagems-a-comparative-study-of-brain-aging-in-healthy-and-patients-with-multiple-sclerosis-104703https://curecurrent.com/trials/bringing-the-outdoors-in-virtual-nature-walks-for-depression-in-multiple-sclerosis-ms-patients-104704https://curecurrent.com/trials/universal-chimeric-antigen-receptor-t-cell-ucar-t-cell-therapy-targeting-cd19-bcma-qt-019c-in-patients-with-r-r-neurolog-104705https://curecurrent.com/trials/treatment-with-full-spectrum-cannabis-extract-of-refractory-epilepsy-associated-with-tuberous-sclerosis-complex-tsc-104706https://curecurrent.com/trials/music-augmented-rhythmic-gait-training-in-multiple-sclerosis-104707https://curecurrent.com/trials/effects-of-ublituximab-on-motor-functions-in-multiple-sclerosis-104708https://curecurrent.com/trials/corevitas-multiple-sclerosis-ms-registry-104709https://curecurrent.com/trials/influence-of-therapeutic-failure-on-the-psychosocial-experience-in-multiple-sclerosis-104710https://curecurrent.com/trials/investigation-of-the-effect-of-the-mind-diet-on-disease-symptoms-in-patients-with-ms-104711https://curecurrent.com/trials/intrathecal-amniotic-fluid-stem-cells-for-progressive-multiple-sclerosis-104712https://curecurrent.com/trials/at-home-use-of-stimulation-suits-for-managing-ms-symptoms-104713https://curecurrent.com/trials/efficacy-and-safety-of-yishen-daluo-yin-granule-for-relapsing-remitting-multiple-sclerosis-104714https://curecurrent.com/trials/prospective-study-to-assess-disease-activity-and-biomarkers-in-minority-participants-with-relapsing-multiple-sclerosis-r-104715https://curecurrent.com/trials/validity-and-reliability-of-the-6-minute-walk-test-over-a-distance-of-6-metres-in-people-with-multiple-sclerosis-104716https://curecurrent.com/trials/oral-cladribine-b-cell-study-104717https://curecurrent.com/trials/car-t-cell-therapy-targeting-cd19-and-bcma-in-patients-with-b-cell-mediated-autoimmune-disease-104718https://curecurrent.com/trials/pathogenicity-of-b-and-cd4-t-cell-subsets-in-multiple-sclerosis-104719https://curecurrent.com/trials/virtual-reality-gamma-sensory-stimulation-for-improving-fatigue-in-people-with-multiple-sclerosis-104720https://curecurrent.com/trials/fecal-microbiota-transplantation-fmt-of-fmp30-in-relapsing-remitting-multiple-sclerosis-104721https://curecurrent.com/trials/rituximab-versus-ocrelizumab-in-relapsing-remitting-multiple-sclerosis-104722https://curecurrent.com/trials/molecular-imaging-of-net-using-c-11-mrb-pet-in-ms-104723https://curecurrent.com/trials/improving-workforce-participation-and-well-being-in-individuals-with-multiple-sclerosis-a-feasability-study-104724https://curecurrent.com/trials/intervention-to-master-complex-fall-risk-situations-in-persons-with-multiple-sclerosis-star-104725https://curecurrent.com/trials/examining-a-wheelchair-exercise-training-intervention-for-persons-with-multiple-sclerosis-104726https://curecurrent.com/trials/action-observation-training-with-3d-virtual-reality-in-patients-with-multiple-sclerosis-104727https://curecurrent.com/trials/respiratory-muscle-strength-and-endurance-cut-offs-in-multiple-sclerosis-104728https://curecurrent.com/trials/indole-3-propionic-acid-clinical-trials-multiple-sclerosis-104729https://curecurrent.com/trials/virtual-versus-usual-in-office-care-for-multiple-sclerosis-virtual-ms-104730https://curecurrent.com/trials/9-month-study-to-assess-the-efficacy-of-ofatumumab-on-microglia-in-patients-with-relapsing-forms-of-multiple-sclerosis-104731https://curecurrent.com/trials/trunk-stability-balance-and-fatigue-in-minimally-to-moderately-disabled-people-with-multiple-sclerosis-104732https://curecurrent.com/trials/multiple-sclerosis-and-fatigue-assessment-104733https://curecurrent.com/trials/impact-of-ocrelizumab-on-cerebrospinal-fluid-biomarkers-at-multiple-sclerosis-onset-104734https://curecurrent.com/trials/chewing-under-dual-tasking-in-ms-104735https://curecurrent.com/trials/validity-and-reliability-of-mixed-reality-based-mobility-tests-in-multiple-sclerosis-104736https://curecurrent.com/trials/tuberous-sclerosis-complex-and-lymphangioleiomyomatosis-pregnancy-registry-tsc-lam-registry-104737https://curecurrent.com/trials/ms-fatigue-and-tdcs-on-fatigue-in-multiple-sclerosis-104738https://curecurrent.com/trials/self-directed-positive-psychology-intervention-for-newly-diagnosed-multiple-sclerosis-104739https://curecurrent.com/trials/home-based-functional-balance-intervention-for-multiple-sclerosis-104740https://curecurrent.com/trials/tongji-nads-cohort-104741https://curecurrent.com/trials/comparison-of-digital-biomarkers-in-subjects-with-radiologically-isolated-syndrome-ris-and-multiple-sclerosis-ms-patient-104742https://curecurrent.com/trials/ms-synchronous-vs-asynchronous-exercise-study-104743https://curecurrent.com/trials/feasibility-of-11c-acetate-pet-in-lam-and-tsc-104744https://curecurrent.com/trials/exploring-the-efficacy-and-safety-of-ofatumumab-in-patients-with-relapsing-multiple-sclerosis-rms-and-its-impact-on-seru-104745https://curecurrent.com/trials/effects-of-dha-in-patients-with-multiple-sclerosis-104746https://curecurrent.com/trials/expain-trial-exercise-an-a-non-pharmacological-pain-relieving-treatment-in-people-with-multiple-sclerosis-104747https://curecurrent.com/trials/a-study-of-c-car168-in-the-treatment-of-central-nervous-system-autoimmune-diseases-refractory-to-standard-therapy-104748https://curecurrent.com/trials/pharmacogenomics-of-drug-safety-in-multiple-sclerosis-104749https://curecurrent.com/trials/a-study-evaluating-b-cell-levels-in-infants-of-lactating-women-with-cis-or-ms-receiving-ocrelizumab-104750https://curecurrent.com/trials/effects-of-deep-sensory-assisted-rehabilitation-on-gait-and-balance-in-patients-with-multiple-sclerosis-104751https://curecurrent.com/trials/study-of-efficacy-and-safety-of-ofatumumab-in-relapsing-multiple-sclerosis-rms-patients-in-china-104752https://curecurrent.com/trials/a-single-arm-study-evaluating-the-efficacy-safety-and-tolerability-of-ofatumumab-in-patients-with-relapsing-multiple-scl-104753https://curecurrent.com/trials/study-of-efficacy-and-safety-of-fingolimod-gilenya-0-5-mg-in-chinese-patients-with-relapsing-multiple-sclerosis-rms-pati-104754https://curecurrent.com/trials/functional-and-quality-of-life-effects-of-the-mollii-neuromodulatory-suit-in-patients-with-stroke-and-multiple-sclerosis-104755https://curecurrent.com/trials/effect-of-training-with-wireless-lightning-reaction-systems-on-cognitive-functions-in-individuals-with-multiple-sclerosi-104756https://curecurrent.com/trials/precision-medicine-for-neurocutaneous-syndromes-in-western-china-104757https://curecurrent.com/trials/assessment-of-synaptic-density-in-ms-104758https://curecurrent.com/trials/glucose-consumption-in-ms-using-f-18-fdg-pet-104759https://curecurrent.com/trials/immune-profiles-in-multiple-sclerosis-ms-patients-and-healthy-volunteers-through-thoracic-duct-cannulation-104760https://curecurrent.com/trials/the-effects-of-aerobi-c-exerci-se-on-neurovascular-uni-t-and-cli-ni-cal-progressi-on-markers-i-n-indi-vi-duals-wi-th-mul-104761https://curecurrent.com/trials/effects-of-exercise-and-sleep-on-motor-learning-and-functional-abilities-in-multiple-sclerosis-104762https://curecurrent.com/trials/intrathecal-administration-of-duoc-01-in-adults-with-primary-progressive-multiple-sclerosis-104763https://curecurrent.com/trials/primary-progressive-multiple-sclerosis-ppms-study-of-bruton-s-tyrosine-kinase-btk-inhibitor-tolebrutinib-sar442168-perse-104764https://curecurrent.com/trials/natalizumab-for-the-treatment-of-people-with-inflammatory-demyelination-suggestive-of-multiple-sclerosis-or-definite-mul-104765https://curecurrent.com/trials/the-effect-of-aerobic-exercise-on-an-elliptical-trainer-versus-a-treadmill-in-people-with-multiple-sclerosis-104766https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-bcd-281-in-patients-with-relapsing-remitting-multiple-sclerosis-104767https://curecurrent.com/trials/contrast-enhanced-3d-t1-weighted-gradient-echo-versus-spin-echo-3-tesla-mr-sequences-in-the-detection-of-active-multiple-104768https://curecurrent.com/trials/allogenic-adipose-tissue-derived-mesenchymal-stromal-cells-for-the-treatment-of-primary-progressive-multiple-sclerosis-104769https://curecurrent.com/trials/evaluation-of-the-impact-of-lesions-of-the-motor-and-proprioceptive-brain-and-pan-medullary-pathways-on-their-clinically-104770https://curecurrent.com/trials/detection-of-spinal-cord-lesions-using-the-mp2rage-sequence-in-inflammatory-diseases-of-the-neuraxis-104771https://curecurrent.com/trials/comparison-of-the-performance-of-an-optimized-3d-epi-swi-sequence-and-a-non-epi-qsm-swi-sequence-in-detecting-the-centra-104772https://curecurrent.com/trials/evaluation-of-new-mri-sequences-including-3d-fgapsir-for-the-optimization-of-inflammatory-spinal-cord-lesions-research-104773https://curecurrent.com/trials/french-registry-for-monitoring-pregnancies-for-multiple-sclerosis-104774https://curecurrent.com/trials/a-study-of-suboptimally-controlled-participants-previously-taking-oral-or-infusion-dmds-for-rms-master-2-104775https://curecurrent.com/trials/escalation-vs-induction-therapy-strategy-in-patients-with-early-onset-ms-after-age-50-104776https://curecurrent.com/trials/study-of-circadian-focused-light-therapy-in-progressive-multiple-sclerosis-104777https://curecurrent.com/trials/role-of-urinary-sphingosine-1-phosphate-as-a-biomarker-for-detrusor-hyperactivity-in-multiple-sclerosis-104778https://curecurrent.com/trials/effects-of-laughter-yoga-on-fatigue-sleep-quality-and-psychological-well-being-in-patients-with-multiple-sclerosis-a-ran-104779https://curecurrent.com/trials/implementation-of-an-advanced-telerehabilitation-solution-for-people-with-multiple-sclerosis-104780https://curecurrent.com/trials/normal-chinese-lifespan-brain-charts-initiative-nclbci-104781https://curecurrent.com/trials/effect-of-ocrelizumab-on-neuroinflammation-in-multiple-sclerosis-as-measured-by-11c-pbr28-mr-pet-imaging-of-microglia-ac-104782https://curecurrent.com/trials/early-versus-late-ofatumumab-kesimpta-use-in-austrian-rms-patients-over-2-years-104783https://curecurrent.com/trials/a-cross-sectional-study-to-assess-the-effectiveness-and-safety-of-ofatumumab-kesimpta-in-patients-with-relapsing-multipl-104784https://curecurrent.com/trials/the-validity-and-reliability-of-the-modified-o-sullivan-functional-balance-mofb-test-for-multiple-sclerosis-104785https://curecurrent.com/trials/prospective-investigation-of-multiple-sclerosis-in-the-three-rivers-region-104786https://curecurrent.com/trials/clinnova-ms-a-prospective-cohort-study-of-patients-with-multiple-sclerosis-switzerland-104787https://curecurrent.com/trials/multiple-sclerosis-versus-neuromyelitis-optica-spectrum-disorder-104788https://curecurrent.com/trials/phase-2-ascending-dose-safety-and-efficacy-study-of-rvp-001-a-manganese-based-mri-contrast-agent-104789https://curecurrent.com/trials/probiotic-intervention-for-people-with-multiple-sclerosis-104790https://curecurrent.com/trials/individualised-cryoneurolysis-to-treat-pain-in-the-context-of-spasticity-in-the-upper-and-lower-extremities-104791https://curecurrent.com/trials/clinically-isolated-syndrome-and-relapsing-remitting-multiple-sclerosis-104792https://curecurrent.com/trials/intermediate-expanded-access-protocol-cnmau8-eap03-104793https://curecurrent.com/trials/emotions-in-multiple-sclerosis-104794https://curecurrent.com/trials/survey-among-healthcare-professionals-and-ms-patients-to-assess-their-understanding-of-rmp-materials-104795https://curecurrent.com/trials/als-phase-ii-study-of-nx210c-104796https://curecurrent.com/trials/implication-of-5-ht7-receptor-in-inflammatory-mechanisms-in-multiple-sclerosis-104797https://curecurrent.com/trials/transcutaneous-tibial-neuro-stimulation-to-improve-voiding-dysfunction-in-multiple-sclerosis-104798https://curecurrent.com/trials/behavioral-intervention-for-physical-activity-and-sexual-dysfunction-in-multiple-sclerosis-104799https://curecurrent.com/trials/project-bipams-behavioral-intervention-for-physical-activity-in-multiple-sclerosis-104800https://curecurrent.com/trials/effects-of-motor-imagery-and-action-observation-in-people-with-multiple-sclerosis-104801https://curecurrent.com/trials/31p-mrs-imaging-to-assess-the-effects-of-cnm-au8-on-impaired-neuronal-redox-state-in-multiple-sclerosis-104802https://curecurrent.com/trials/walking-fatigability-and-brain-activity-in-people-with-multiple-sclerosis-104803https://curecurrent.com/trials/disease-progression-in-ms-104804https://curecurrent.com/trials/prospective-longitudinal-monocentric-study-to-evaluate-the-syde-digital-endpoint-in-patients-with-multiple-sclerosis-104805https://curecurrent.com/trials/a-study-of-vrg50635-in-participants-with-amyotrophic-lateral-sclerosis-als-104806https://curecurrent.com/trials/universal-chimeric-antigen-receptor-t-cell-ucar-t-cell-therapy-targeting-cd19-b-cell-maturation-antigen-cd19-bcma-in-pat-104807https://curecurrent.com/trials/clinical-impact-through-ai-assisted-ms-care-a-retrospective-multi-center-observational-study-104808https://curecurrent.com/trials/ccmr-two-a-phase-iia-randomised-double-blind-placebo-controlled-trial-of-the-ability-of-the-combination-of-metformin-and-104809https://curecurrent.com/trials/linking-optic-nerve-mri-and-the-retinal-axonal-loss-after-optic-neuritis-104810https://curecurrent.com/trials/description-des-troubles-respiratoires-chez-les-patients-suivis-pour-une-scl-rose-en-plaques-sep-s-v-re-104811https://curecurrent.com/trials/effect-of-hydrotherapy-on-multiple-sclerosis-104812https://curecurrent.com/trials/peripheral-immunological-effects-of-high-dose-vitamin-d-treatment-in-healthy-subjects-104813https://curecurrent.com/trials/home-based-action-observation-treatment-with-virtual-reality-for-arm-rehabilitation-in-people-with-multiple-sclerosis-104814https://curecurrent.com/trials/clinical-impact-through-ai-assisted-ms-care-a-prospective-multi-center-study-104815https://curecurrent.com/trials/multimodal-imaging-signatures-of-the-biological-mechanisms-underlying-neurodegeneration-in-multiple-sclerosis-104816https://curecurrent.com/trials/autonomic-dysfunction-in-neuromyelitis-optica-spectrum-disorder-and-multiple-sclerosis-a-comparative-study-104817https://curecurrent.com/trials/senolytics-for-secondary-progressive-ms-104818https://curecurrent.com/trials/cladribine-tablets-after-treatment-with-natalizumab-cladrina-104819https://curecurrent.com/trials/effects-of-lower-extremity-neuromuscular-facilitation-and-patients-with-multiple-sclerosis-104820https://curecurrent.com/trials/managed-access-program-map-for-patients-diagnosed-with-secondary-progressive-multiple-sclerosis-with-active-disease-104821https://curecurrent.com/trials/libyan-multiple-sclerosis-registry-study-104822https://curecurrent.com/trials/a-multicenter-clinical-trial-evaluating-the-efficacy-and-safety-of-taurine-as-an-adjunctive-therapy-in-multiple-sclerosi-104823https://curecurrent.com/trials/effect-of-ttns-and-pns-on-neurogenic-overactive-bladder-symptoms-in-female-patients-with-multiple-sclerosis-104824https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-in-ms-induced-spastic-paraparesis-104825https://curecurrent.com/trials/upper-limb-muscle-strength-models-for-patients-with-motor-impairment-104826https://curecurrent.com/trials/clinical-monitoring-mri-and-neuro-ophthalmology-of-a-cohort-of-patients-with-a-clinically-isolated-syndrome-cis-104827https://curecurrent.com/trials/open-label-long-term-safety-study-of-lp352-in-subjects-with-developmental-and-epileptic-encephalopathy-104828https://curecurrent.com/trials/a-study-to-investigate-arbaclofen-er-tablets-for-the-treatment-of-spasticity-in-patients-with-multiple-sclerosis-104829https://curecurrent.com/trials/rehabilitation-protocol-for-disorders-on-hand-sensitivity-in-multiple-sclerosis-patients-104830https://curecurrent.com/trials/deficit-specific-training-in-spinal-disorders-104831https://curecurrent.com/trials/comparison-of-structured-exercise-and-exergaming-in-pediatric-onset-multiple-sclerosis-104832https://curecurrent.com/trials/environmental-risk-factors-in-multiple-sclerosis-development-epidemiological-study-of-ebv-infection-and-vitamin-d-defici-104833https://curecurrent.com/trials/personalized-nutrition-advice-for-optimizing-dietary-calcium-intake-in-ms-patients-104834https://curecurrent.com/trials/comprehensive-therapeutic-program-for-people-with-multiple-sclerosis-104835https://curecurrent.com/trials/topical-sirolimus-ointment-for-cutaneous-angiofibromas-in-subjects-with-tuberous-sclerosis-complex-104836https://curecurrent.com/trials/prognostic-value-of-three-new-biomarkers-of-multiple-sclerosis-in-patients-with-radiologically-isolated-syndrome-104837https://curecurrent.com/trials/special-drug-use-surveillance-for-kesimpta-for-s-c-injection-20-mg-pen-104838https://curecurrent.com/trials/observational-study-of-the-effect-of-ozanimod-on-fatigue-in-multiple-sclerosis-patients-104839https://curecurrent.com/trials/prospective-case-series-to-refine-standalone-cognitive-behavioral-therapy-components-for-multiple-sclerosis-fatigue-104840https://curecurrent.com/trials/study-of-ovarian-reserve-concerning-patients-with-multiple-sclerosis-ms-compared-to-a-control-group-104841https://curecurrent.com/trials/a-study-to-evaluate-efficacy-safety-pharmacokinetics-and-pharmacodynamics-of-multiple-doses-of-natalizumab-bg00002-admin-104842https://curecurrent.com/trials/immune-system-effects-in-children-born-to-women-with-multiple-sclerosis-treated-with-monoclonal-antibody-therapy-during-104843https://curecurrent.com/trials/evaluation-of-the-clinical-contribution-of-quantitative-mri-in-neuro-imaging-104844https://curecurrent.com/trials/ocrelizumab-access-by-socio-economic-status-104845https://curecurrent.com/trials/investigating-the-effects-of-wearable-robotic-exoskeleton-for-improving-mobility-and-cognition-in-persons-with-ms-104846https://curecurrent.com/trials/preg-ms-new-england-ms-pregnancy-registry-104847https://curecurrent.com/trials/real-world-experience-of-oral-agents-on-fatigability-in-multiple-sclerosis-104848https://curecurrent.com/trials/metformin-as-an-add-on-or-monotherapy-in-treatment-of-aging-people-with-multiple-sclerosis-ms-104849https://curecurrent.com/trials/home-based-self-management-and-cognitive-training-changes-lives-hobscotch-multiple-sclerosis-ms-104850https://curecurrent.com/trials/effects-of-dual-task-training-in-people-with-multiple-sclerosis-104851https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-and-safety-effects-following-coadministration-of-carbamazepine-or-itraconazole-wi-104852https://curecurrent.com/trials/usability-of-the-metime-ms-app-104853https://curecurrent.com/trials/hb-admscs-for-the-treatment-of-patients-with-multiple-sclerosis-104854https://curecurrent.com/trials/a-study-on-the-safety-of-ozanimod-exposure-in-pregnant-women-and-their-offspring-104855https://curecurrent.com/trials/comparison-of-efficacy-and-safety-in-patients-switching-from-mabthera-to-rixathon-in-relapsing-remitting-multiple-sclero-104856https://curecurrent.com/trials/phase-1-open-label-drug-drug-interaction-study-to-assess-effect-between-radiprodil-and-the-co-administered-drugs-104857https://curecurrent.com/trials/a-study-of-obexelimab-in-patients-with-relapsing-multiple-sclerosis-moonstone-104858https://curecurrent.com/trials/narcoms-registry-a-multiple-sclerosis-registry-104859https://curecurrent.com/trials/prepare-the-mind-can-coaching-in-goal-directed-behaviour-increase-the-success-of-cognitive-rehabilitation-in-people-with-104860https://curecurrent.com/trials/efgartigimod-for-the-treatment-of-acute-optic-neuritis-104861https://curecurrent.com/trials/assessment-of-adjunctive-cannabidiol-oral-solution-gwp42003-p-in-children-with-tuberous-sclerosis-complex-tsc-dravet-syn-104862https://curecurrent.com/trials/selfie-videos-a-novel-patient-centered-comprehensive-approach-to-measuring-function-in-ms-104863https://curecurrent.com/trials/effects-of-cycling-and-virtual-reality-on-thinking-speed-in-persons-with-ms-pace-ms-104864https://curecurrent.com/trials/hobscotch-ms-efficacy-trial-104865https://curecurrent.com/trials/oer-glibenclamide-for-neuropathic-pain-in-multiple-sclerosis-104866https://curecurrent.com/trials/a-study-of-diroximel-fumarate-drf-in-adult-participants-from-the-asia-pacific-region-with-relapsing-forms-of-multiple-sc-104867https://curecurrent.com/trials/long-term-safety-and-efficacy-study-of-tolebrutinib-sar442168-in-participants-with-relapsing-multiple-sclerosis-104868https://curecurrent.com/trials/a-pilot-randomized-controlled-trial-cointegrate-104869https://curecurrent.com/trials/effect-of-alemtuzumab-on-microglial-activation-positron-emission-tomography-pet-in-multiple-sclerosis-104870https://curecurrent.com/trials/a-study-to-evaluate-long-term-safety-of-vumerity-and-tecfidera-in-participants-with-multiple-sclerosis-ms-104871https://curecurrent.com/trials/study-of-safety-and-proof-of-the-mechanism-of-blz945-in-als-patients-104872https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-sar443820-on-serum-neurofilament-levels-in-male-and-female-adult-participants-with-mul-104873https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-effect-on-disease-progression-of-biib105-in-participants-with-amyotrophic-104874https://curecurrent.com/trials/comparing-telehealth-delivered-cbt-i-to-web-based-cbt-i-to-enhance-sleep-reduce-fatigue-and-promote-neuroprotection-104875https://curecurrent.com/trials/relationship-between-cognition-workforce-participation-and-well-being-in-individuals-with-multiple-sclerosis-104876https://curecurrent.com/trials/prognostic-value-of-cerebrospinal-fluid-immunoglobulin-free-light-chains-in-patients-with-multiple-sclerosis-104877https://curecurrent.com/trials/chronic-fatigue-in-multiple-sclerosis-ms-copilot-boost-solution-compared-to-standard-care-104878https://curecurrent.com/trials/biobank-for-ms-and-other-demyelinating-diseases-104879https://curecurrent.com/trials/the-relationship-between-mechanical-properties-of-respiratory-and-lower-extremity-muscles-and-other-parameters-in-multip-104880https://curecurrent.com/trials/mscopilot-users-feedback-in-real-life-outcomes-regarding-integration-in-patients-pathway-and-users-experience-104881https://curecurrent.com/trials/central-vein-sign-a-diagnostic-biomarker-in-multiple-sclerosis-104882https://curecurrent.com/trials/a-study-to-describe-the-switching-from-a-first-or-second-line-disease-modifying-therapy-dmt-to-ozanimod-in-participants-104883https://curecurrent.com/trials/open-label-study-of-adjunctive-gnx-treatment-in-children-and-adults-with-tsc-related-epilepsy-104884https://curecurrent.com/trials/serum-neurofilaments-and-gfap-in-atypical-multiple-sclerosis-104885https://curecurrent.com/trials/sexual-dysfunction-in-women-with-multiple-sclerosis-ms-104886https://curecurrent.com/trials/randomized-double-blind-phase-2-efficacy-and-safety-of-autologous-hb-mscs-vs-placebo-for-treatment-of-multiple-sclerosis-104887https://curecurrent.com/trials/clinical-study-of-regulatory-t-cells-tregs-in-the-treatment-of-neurodegenerative-diseases-104888https://curecurrent.com/trials/neuromuscular-electrostimulation-in-multiple-sclerosis-people-with-dysphagia-104889https://curecurrent.com/trials/impact-of-the-cionic-neural-sleeve-on-mobility-in-multiple-sclerosis-104890https://curecurrent.com/trials/interest-of-immersive-virtual-reality-on-stress-during-botulinum-toxin-injections-in-spasticity-rvtox-104891https://curecurrent.com/trials/evaluation-of-the-relationship-between-abcg2-mutation-and-teriflunomide-exposure-and-safety-in-chinese-rms-patients-trea-104892https://curecurrent.com/trials/a-phase-i-double-blind-study-of-metformin-acting-on-endogenous-neural-progenitor-cells-in-children-and-young-adults-with-104893https://curecurrent.com/trials/atomic-active-teens-multiple-sclerosis-physical-activity-research-program-104894https://curecurrent.com/trials/study-of-excretion-balance-and-pharmacokinetics-of-14c-sar442168-in-healthy-male-subjects-104895https://curecurrent.com/trials/validity-and-reliability-of-the-l-test-in-single-and-dual-task-conditions-in-multiple-sclerosis-104896https://curecurrent.com/trials/tandem-2-closing-the-gap-to-interventions-for-tand-104897https://curecurrent.com/trials/role-of-microglia-in-the-pathogenesis-of-progressive-multiple-sclerosis-104898https://curecurrent.com/trials/analysis-of-balance-disorders-after-botulinum-toxin-treatment-in-the-rectus-femoris-in-patients-with-a-stiff-knee-gait-104899https://curecurrent.com/trials/does-microglial-activation-promote-lesion-growth-and-progression-among-multiple-sclerosis-patients-104900https://curecurrent.com/trials/kappa-free-light-chains-kflc-in-multiple-sclerosis-ms-and-clinically-isolated-syndrome-cis-104901https://curecurrent.com/trials/efficiency-of-spatially-distributed-sequential-stimulation-sdss-for-functional-electrical-stimulation-fes-of-upper-motor-104902https://curecurrent.com/trials/multiple-sclerosis-patient-experience-on-kesimpta-and-ocrevus-subcutaneous-formulation-104903https://curecurrent.com/trials/stimulation-of-acupuncture-points-in-female-patients-with-multiple-sclerosis-and-neurogenic-bladder-dysfunction-104904https://curecurrent.com/trials/telerehabilitation-for-multiple-sclerosis-104905https://curecurrent.com/trials/prospective-evaluation-of-sequencing-from-anticd-20-therapies-to-ozanimod-104906https://curecurrent.com/trials/understanding-the-durable-effect-concept-of-b-cell-modulating-therapies-104907https://curecurrent.com/trials/assessing-the-effects-of-ongoing-ocrelizumab-ocr-therapy-on-fatigue-and-cognition-in-veterans-with-multiple-sclerosis-104908https://curecurrent.com/trials/study-of-drug-drug-interaction-of-the-effects-of-gemfibrozil-and-rifampicin-on-sar442168-in-healthy-adult-subjects-104909https://curecurrent.com/trials/comparing-the-acute-effects-of-different-exercise-approaches-in-patients-with-multiple-sclerosis-104910https://curecurrent.com/trials/impact-of-a-tele-rehabilitation-program-on-people-with-multiple-sclerosis-104911https://curecurrent.com/trials/lifestyle-physical-activity-intervention-for-persons-newly-diagnosed-with-multiple-sclerosis-104912https://curecurrent.com/trials/assessment-of-clemastine-fumarate-as-a-remyelinating-agent-in-multiple-sclerosis-104913https://curecurrent.com/trials/physiological-effects-of-n-acetyl-cysteine-in-patients-with-multiple-sclerosis-104914https://curecurrent.com/trials/dose-finding-study-for-sar442168-in-relapsing-multiple-sclerosis-104915https://curecurrent.com/trials/oct-a-and-perimetry-in-multiple-sclerosis-104916https://curecurrent.com/trials/montpellier-prospective-cohort-in-relapsing-remitting-multiple-sclerosis-using-imaging-and-serologic-104917https://curecurrent.com/trials/a-clinical-trial-to-assess-pharmacokinetic-profiles-safety-and-tolerability-of-ivl3004-and-ivl4002-in-healthy-male-subje-104918https://curecurrent.com/trials/use-of-stromal-vascular-fraction-in-multiple-sclerosis-104919https://curecurrent.com/trials/a-real-world-study-about-the-impact-of-siponimod-treatment-on-secondary-progressive-multiple-sclerosis-patients-in-russi-104920https://curecurrent.com/trials/spincoms-biomarker-study-104921https://curecurrent.com/trials/neurophysiological-effects-of-transcutaneous-electrical-nerve-stimulation-in-persons-with-ms-104922https://curecurrent.com/trials/evaluation-of-the-impact-of-multiple-sclerosis-and-its-treatments-on-women-fertility-104923https://curecurrent.com/trials/vr-based-optokinetic-stimulation-in-multiple-sclerosis-104924https://curecurrent.com/trials/a-study-investigating-the-utilization-effectiveness-and-quality-of-life-in-clinical-practice-in-germany-for-participants-104925https://curecurrent.com/trials/effects-of-tdcs-and-cognitive-rehabilitation-on-cognition-and-neural-plasticity-in-ms-patients-104926https://curecurrent.com/trials/turkish-validity-and-reliability-of-the-core-lower-urinary-tract-symptoms-questionnaire-in-individuals-with-multiple-scl-104927https://curecurrent.com/trials/a-phase-iib-multi-center-multinational-double-blind-placebo-controlled-study-with-an-open-label-extension-to-evaluate-sa-104928https://curecurrent.com/trials/yoga-in-multiple-sclerosis-patients-104929https://curecurrent.com/trials/remediation-program-via-a-serious-game-for-the-cognitive-functions-of-multiple-sclerosis-patients-104930https://curecurrent.com/trials/depression-and-facial-identity-recognition-abilities-in-patients-with-multiple-sclerosis-104931https://curecurrent.com/trials/a-feasibility-pilot-study-on-lee-silverman-voice-treatment-loud-a-telerehabilitation-approach-104932https://curecurrent.com/trials/treatment-of-pendular-nystagmus-with-gabapentin-and-memantine-in-patients-with-multiple-sclerosis-104933https://curecurrent.com/trials/pilot-study-of-tscs-for-improving-upper-limb-function-in-people-with-multiple-sclerosis-104934https://curecurrent.com/trials/chronic-optic-neuropathy-in-multiple-sclerosis-104935https://curecurrent.com/trials/treatment-of-pendular-nystagmus-in-opt-104936https://curecurrent.com/trials/testing-the-effects-of-methylphenidate-on-multiple-sclerosis-104937https://curecurrent.com/trials/evaluation-of-the-relationship-between-optic-nerve-diameter-and-optic-nerve-sheath-diameter-measured-by-transorbital-son-104938https://curecurrent.com/trials/allogeneic-mesenchymal-stem-cell-derived-exosome-therapy-for-progressive-multiple-sclerosis-104939https://curecurrent.com/trials/predictive-value-of-the-optic-nerve-involvement-in-clinically-isolated-syndrome-104940https://curecurrent.com/trials/an-individualized-health-elibrary-app-for-people-with-multiple-sclerosis-104941https://curecurrent.com/trials/a-health-action-process-approach-online-intervention-for-people-with-multiple-sclerosis-104942https://curecurrent.com/trials/a-phase-iv-study-of-dimethyl-fumarate-enteric-coated-capsules-for-relapsing-multiple-sclerosis-rms-104943https://curecurrent.com/trials/prospective-randomized-endovascular-therapy-in-multiple-sclerosis-104944https://curecurrent.com/trials/evaluation-of-the-wheelchair-school-drivkraft-a-clinical-study-104945https://curecurrent.com/trials/effect-of-resistance-training-on-psychophysiological-indicators-in-people-with-multiple-sclerosis-104946https://curecurrent.com/trials/serum-25-hydroxyvitamin-d-and-neurological-disability-in-multiple-sclerosis-104947https://curecurrent.com/trials/a-clinical-trial-evaluating-the-safety-and-efficacy-of-myelin-peptide-loaded-toldc-as-treatment-for-ms-104948https://curecurrent.com/trials/effects-of-exopulse-mollii-suit-on-spasticity-and-functionality-in-multiple-sclerosis-patients-104949https://curecurrent.com/trials/cortical-inhibition-in-patients-with-multiple-sclerosis-104950https://curecurrent.com/trials/modafims-a-trial-to-evaluate-predictors-of-response-to-modafinil-in-patients-with-multiple-sclerosis-104951https://curecurrent.com/trials/improving-hand-movement-and-coordination-in-people-with-multiple-sclerosis-using-transcranial-magnetic-stimulation-tms-a-104952https://curecurrent.com/trials/impact-of-anodal-tdcs-and-virtual-reality-on-cognitive-dysfunction-in-patients-with-multiple-sclerosis-104953https://curecurrent.com/trials/sarcopenia-and-related-factors-in-patients-with-multiple-sclerosis-104954https://curecurrent.com/trials/evaluate-the-safety-and-efficacy-of-allogeneic-umbilical-cord-mesenchymal-stem-cells-in-patients-with-multiple-sclerosis-104955https://curecurrent.com/trials/task-oriented-training-intervention-for-multiple-sclerosis-patients-104956https://curecurrent.com/trials/evaluation-of-the-neuroswing-orthosis-on-walking-speed-in-a-population-with-dorsal-and-or-plantar-flexor-deficits-with-a-104957https://curecurrent.com/trials/pet-study-of-pipe-791-in-healthy-volunteers-and-volunteers-with-prms-and-ipf-104958https://curecurrent.com/trials/luna-emg-to-enhance-motor-functions-in-multiple-sclerosis-104959https://curecurrent.com/trials/central-nervous-system-changes-following-onabotulinumtoxina-injection-in-the-bladder-104960https://curecurrent.com/trials/exercise-induced-irisin-and-brain-changes-104961https://curecurrent.com/trials/a-phase-1-study-to-investigate-the-safety-and-pharmacokinetics-of-fosigotifator-in-patients-with-amyotrophic-lateral-scl-104962https://curecurrent.com/trials/the-effect-of-reflexology-and-pelvic-floor-muscle-exercises-kegel-on-urinary-incontinence-in-ms-patients-104963https://curecurrent.com/trials/examination-of-a-self-compassion-course-for-healthcare-providers-working-with-people-with-multiple-sclerosis-104964https://curecurrent.com/trials/a-study-of-mk-2225-in-healthy-participants-mk-2225-003-104965https://curecurrent.com/trials/assessment-of-transcranial-alternating-current-stimulation-s-clinical-efficacy-in-treating-cognitive-impairment-of-idiop-104966https://curecurrent.com/trials/a-study-of-c-car168-in-the-treatment-of-autoimmune-diseases-refractory-to-standard-therapy-104967https://curecurrent.com/trials/neuropsychological-management-of-multiple-sclerosis-benefits-of-a-computerised-semi-autonomous-at-home-cognitive-rehabil-104968https://curecurrent.com/trials/postural-control-and-psychosocial-measures-associations-in-multiple-sclerosis-104969https://curecurrent.com/trials/effects-of-reiki-and-self-acupressure-applications-104970https://curecurrent.com/trials/metformin-treatment-in-progressive-multiple-sclerosis-104971https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ro7303509-in-participants-with-systemic-sclerosis-104972https://curecurrent.com/trials/robotic-assisted-rehabilitation-for-multiple-sclerosis-an-adaptive-approach-for-individualized-therapy-104973https://curecurrent.com/trials/incremental-vestibulo-ocular-reflex-adaptation-as-a-novel-treatment-for-dizziness-in-people-with-multiple-sclerosis-104974https://curecurrent.com/trials/corticosteroid-effects-on-asymptomatic-gadolinium-enhancing-lesions-in-multiple-sclerosis-104975https://curecurrent.com/trials/cognitive-markers-in-prodromal-ms-104976https://curecurrent.com/trials/effect-of-cooling-vest-in-multiple-sclerosis-patients-104977https://curecurrent.com/trials/technological-balance-and-gait-rehabilitation-in-patients-with-multiple-sclerosis-104978https://curecurrent.com/trials/adjunctive-gnx-treatment-compared-with-placebo-in-children-and-adults-with-tsc-related-epilepsy-104979https://curecurrent.com/trials/woe-of-anti-cd20-therapies-104980https://curecurrent.com/trials/a-study-of-khk4827-in-patients-with-systemic-sclerosis-104981https://curecurrent.com/trials/unravelling-the-optimisation-and-consolidation-of-motor-skills-in-people-with-multiple-sclerosis-with-severe-gait-impair-104982https://curecurrent.com/trials/unravelling-the-optimisation-and-consolidation-of-motor-skills-in-people-with-multiple-sclerosis-with-mild-to-moderate-g-104983https://curecurrent.com/trials/motor-cognitive-performance-in-people-with-multiple-sclerosis-104984https://curecurrent.com/trials/exploring-the-profiles-of-rms-patients-on-ofatumumab-or-ocrelizumab-in-a-real-world-setting-in-the-gulf-104985https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-safety-and-tolerability-of-subcutaneous-ocrelizumab-administration-in-partic-104986https://curecurrent.com/trials/effects-of-a-circuit-training-on-balance-in-persons-with-multiple-sclerosis-104987https://curecurrent.com/trials/impact-of-direct-current-electrical-stimulation-on-spasticity-levels-and-functional-muscle-use-in-ms-104988https://curecurrent.com/trials/the-neural-mechanisms-of-split-belt-treadmill-adaptation-in-people-with-multiple-sclerosis-104989https://curecurrent.com/trials/aba-101-in-participants-with-progressive-multiple-sclerosis-104990https://curecurrent.com/trials/relapsing-forms-of-multiple-sclerosis-rms-study-of-bruton-s-tyrosine-kinase-btk-inhibitor-tolebrutinib-sar442168-gemini-104991https://curecurrent.com/trials/nonrelapsing-secondary-progressive-multiple-sclerosis-nrspms-study-of-bruton-s-tyrosine-kinase-btk-inhibitor-tolebrutini-104992https://curecurrent.com/trials/relapsing-forms-of-multiple-sclerosis-rms-study-of-bruton-s-tyrosine-kinase-btk-inhibitor-tolebrutinib-sar442168-gemini-104993https://curecurrent.com/trials/telerehabilitation-of-multidomain-cognitive-impairment-in-multiple-sclerosis-104994https://curecurrent.com/trials/simvastatin-in-secondary-progressive-multiple-sclerosis-104995https://curecurrent.com/trials/totem-rrms-testosterone-treatment-on-neuroprotection-and-myelin-repair-in-relapsing-remitting-multiple-sclerosis-104996https://curecurrent.com/trials/3d-optimized-wmn-mprage-increased-detection-of-focal-spinal-cord-lesion-in-multiple-sclerosis-whinume-104997https://curecurrent.com/trials/study-of-spg302-in-healthy-volunteers-and-als-participants-104998https://curecurrent.com/trials/ocrelizumab-versus-rituximab-off-label-at-the-onset-of-relapsing-ms-disease-104999https://curecurrent.com/trials/exopulse-mollii-suit-spasticity-tissue-oxygenation-105000https://curecurrent.com/trials/a-post-authorization-long-term-study-of-ozanimod-real-world-safety-105001https://curecurrent.com/trials/effectiveness-of-the-combination-strategy-of-disease-modifying-therapy-and-the-yishen-daluo-yin-modified-formula-for-mul-105002https://curecurrent.com/trials/exergaming-with-immersive-virtual-reality-for-people-with-multiple-sclerosis-exerviem-105003https://curecurrent.com/trials/optical-coherence-tomography-and-optic-neuritis-not-related-to-multiple-sclerosis-105004https://curecurrent.com/trials/randomized-autologous-hematopoietic-stem-cell-transplantation-versus-alemtuzumab-cladribine-or-ocrelizumab-for-rrms-ram-105005